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ABSTRACT
Vast amount of experimental data in structural biology has been generated, collected
and accumulated in the last few decades. This rich dataset is an invaluable mine of knowl-
edge, from which deep insights can be obtained and practical applications can be devel-
oped. To achieve that goal, we must be able to manage such “Big Data” in science and
investigate them expertly. Molecular docking is a field that can prominently make use of
the large structural biology dataset. As an important component of rational drug design,
molecular docking is used to perform large-scale screening of putative associations between
small organic molecules and their pharmacologically relevant protein targets. Given a small
molecule (ligand), a molecular docking program simulates its interaction with the target
protein, and reports the probable conformation of the protein-ligand complex, and the
relative binding affinity compared against other candidate ligands.
This dissertation collects my contributions in several aspects of molecular docking. My
early contribution focused on developing a novel metric to quantify the structural similarity
between two protein-ligand complexes. Benchmarks show that my metric addressed several
issues associated with the conventional metric. Furthermore, I extended the functionality
of this metric to cross different systems, effectively utilizing the data at the proteome
level. After developing the novel metric, I formulated a scoring function that can extract
the biological information of the complex, integrate it with the physics components, and
finally enhance the performance. Through collaboration, I implemented my model into
an ultra-fast, adaptive program, which can take advantage of a range of modern parallel





This thesis discusses how to improve the rational drug design by taking advantage of
the abundant data, often referred as the Big Data, in structural biology.
1.1 Data-intensive scientific exploration
Big Data has become the buzzword of the day [1,2]. The term was firstly introduced in
the commercial world [3], referred as the data sets and analytical techniques in applications
that are so large (from terabytes to exabytes) and complex (from sensor to social media
data) that they require advanced and unique data data storage, management, analysis and
visualization technologies [4]. Information technology companies are the first few Big Data
players. Google invented the MapReduce technology to be able to analyze billions of web
sites across the world [5]. E-commerce platforms such as Amazon collect user search and
interaction logs on a 24/7 basis in order to better understand the customer needs and
identify new business opportunities [6, 7]. Even in more conventional industries, Big Data
can also play a pivotal role [8]. A typical example is that supply chain management applies
large scale predictive analytics to enhance the efficiency by estimating past and future levels
of integration of business processes among functions or companies [2].
Apart from the commercial world, Big Data is emerging as a new, fourth paradigm
for scientific exploration [9]. Science used to be categorized as either experimental or the-
oretical. Then, for many problems the theoretical models grew too complicated to solve
analytically, and simulation as the third paradigm came forth. Today, researchers are expe-
riencing a moving from data paucity to a data plethora that unprecedented amount of data
are being generated by simulations and experiments. This ready availability of diverse data
is shifting scientific approaches from the traditional, hypothesis-driven scientific method to
methods more exploration-based [10, 11]. Since the techniques and methodologies to con-
duct such exploration are so different that it is worth distinguishing such approach from
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computational science as a new, fourth paradigm for scientific exploration, data-intensive
scientific exploration(DISE) [9].
DISE consists of three basic and consecutive activities: data capture, curation and
analysis [1].
Data in DISE comes in a variety of scales and shape, covering large international ex-
periments; cross-laboratory, single-laboratory, individual observations [9]; and even poten-
tially individual lives [12]. Large international experiments, such as the Australia Square
Kilometre Array of radio telescope project [13], CERN’s Large Hadron Collider [14], and
Pan-STARRS [15] array of celestial telescopes are capable of generating several petabytes
of data per day. Being shared by many different research teams, these large data detec-
tors usually conform to a very standard way to codify the raw data. Data from other
disciplines can be much more heterogeneous. In ecological science, data are generated by a
wide variety of groups using a wide range of sampling or simulation methodologies and data
standards [16]. Similarly in bioinformatics, data can range from metabolic pathways to the
behavior of a cell to the structure of proteins [17, 18]. To facilitate the data sharing and
promote the collaboration between different research group, considerable amount of work
was devoted into developing programs to translate data between different forms [19,20]
Data curation is as much important as data capture and analysis. Without proper
assembling, organizing and maintaining of the data, scientists can not guarantee data
quality, or data reusing and preservation over time [1]. Notwithstanding that the first
data-driven scientific discovery can date back to 400 years ago, when Johannes Kepler
took Brache’s catalog of systematic astronomical observations and discovered the laws of
planetary motion, through the 20th century, data sit “under-analyzed in databases all over
the world” [21]. Most of the data on which scientific theories were based was often buried in
individual scientific notebooks, which were likely to be thrown out when a scientist retires,
or at best be held in libraries until it is discarded. Long-term data provenance as well
as community access to distributed data were the main challenges [22]. Recognizing the
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growing importance of data curation and communication for scientific research, the National
Science Board of the National Science Foundation published “Long-Live Digital Collections:
Enabling Research and Education in the 21st Century” [23]. This report highlighted the
urgency to build cyberinfrastructures to facilitate DISE. National Center for Atmospheric
Research (NCAR) [24] is one of the first few sites for the modeling, collective and curation of
Earth science data. The San Diego Supercomputer Center [25], though normally associated
with supplying computational power to scientific computation, recognized the need to add
data to its mission, and set aside 400 terabytes of disk space for both public and private
databases in 2009. There are also commercial incentives to address the infrastructure needs
in science. Arend Sidow, a computational biologist at Stanford University, co-founded a
company called DNAnexus as a platform for sharing and management of genomic data and
tools to accelerate genomics study [26].
Being able to collect and maintain massive amount of scientific data only lays the
foundation of DISE. In order to have insights into those vexing questions that previously
would have been infeasible to address, it is crucial to be able to analyze the data expertly
[27,28].
At the core of analytics in DISE is machine learning (ML), an important subject of
artificial intelligence which aims to design algorithms that allow computers to evolve behav-
iors based on empirical data [1, 29, 30]. It is interesting to note that ML has been applied
to a wide variety of scientific fields [31], including astronomy [32], particle physics [33],
bioinformatics [34], social science [27], medical health et al [11,35]. While each field has its
own version of scientific process, the cycle of observing, creating hypotheses, testing and
iteratively building up comprehensive testable models or theories is shared cross disciplines.
For each stage of this abstracted scientific process, there are relevant developments in ML
that will lead to semiautomatic supportive tools [31].
At the outset of DISE, exploration of high volume of data can be greatly facilitated by
various ML techniques when the data can hardly be handled by human perception. Pattern
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recognition has been adopted by particle physics for decades for significant events detection
[33]. A recent example is event analysis for Cherenkov detectors used in neutrino oscillation
experiments [36]. Another promising approach is dimensionality reduction: reducing data
from many original dimensions (e.g., thousands of gene expression measurements) to just
a few dimensions in a new space, for the purpose of easier visualization on computer
display [37]. Clustering of coexpressed genes is often used in expression bioinformatics to
investigate direct or indirect coregulation [38].
ML techniques discussed above provide researcher with better tools to perceive the
raw data and formulate hypotheses. In addition, ML can assist studying and validating
the hypotheses using a handful of methods developed by the community to learn good
models from the data. Specifically, when the observed data can be labeled by a scientist
as continuous numbers, or categorical values as “positive” and “negative”, supervised ML
models can be learned to predict the labels. It should be noted that label prediction can
not ultimately replace the more traditional component of the scientific method [39]. While
supervised ML models try to generalize regularities from the data to make predictions,
science aims to employ those regularities to construct a unified means of understanding
them a priori. In that case, models that include the learning of causal mechanisms are
more suitable (e.g., Bayesian networks, graphical models, or nonlinear regression [40]).
This type of ML models are named Generative models. The other type of ML models,
a.k.a Discriminative models, strive only to capture the ability to make predictions, while
making no attempt to explicitly capture the true underlying physics of the phenomena.
However, discriminative models can also provide insights into the nature [31]. Many recent
successful applications of Discriminative models gives valuable information, including such
aspects as which input dimensions are most useful, which examples are most likely to be
outliers, and what new observations might be most worthwhile to gather [41, 42].
DISE relies on cloud computing and parallel computing to manage and speed up the
processing of the unprecedented quantity of data. Cloud computing centers are built with
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the basic idea that “algorithm and calculation should be brought to the data instead of
the other way around”. Because the size of data is much larger than the program, it is
too expensive and inefficient to download the data and analyze locally. In that regard,
cloud computing centers usually consist of two components, a data center serving as the
“Big Data parking lots” where data resides, in addition to a computing center serving
as the “processing workhorse” where data are analyzed. Large cloud computing centers
create economies of scale in facility design and construction, equipment acquisition and
maintenance, mitigating the possible technical barriers for individual laboratories [43].
Parallel computing in DISE takes place usually in two forms. The first form is the
so-called “embarrassing parallelism”, where many independent data processing tasks are
simply partitioned over multiple computing nodes while no communication is required in
between. Such type of data analysis appears repeatedly in large-scale scientific analyses.
For example, consider the task of matching one gene sequence against millions of tem-
plate gene sequences [44], or searching for anomalies in scans of brain images [45]. While
“embarrassing parallelism” seeks to speed up the processing at the task level using multi-
ple nodes, parallelism can also be exploited at the hardware level of each individual node
and/or across the nodes, which I call “serious parallelism”. This paradigm of parallelism
involves more data sharing and message exchanging using programming models such as
MPI [46], OpenMP [47] and CUDA [48]. Conducted at a very low level of abstraction,
these programming models often requires the codes be broken into components that run
on specific processor. In many ways, the state of “serious parallelism” nowadays is similar
to the early days of computing, when programs were written in assembly languages for a
specific architecture and had to be rewritten to run on a different machine. In the case
of “serious parallelism” in DISE, one huge advantages of coding in low-level languages is
ultra-fast processing speed, but that is at the cost of low reusability and great difficulty for
the domain scientists who prefer high-level languages such as Matlab and Python.
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In Chapter 4, GeauxDock computing, I will discuss how to strike a balance between
code-reusing and platform-crossing.
1.2 Rational drug design
Drug discovery is a process of identifying a small group of bioactive compounds from
a vast collection of candidates. Specifically, drugs are those compounds that can bind and
modulate the function of a target protein implicated in a disease state. A drug molecule
must prossess a certain geometry and physicochemical properties in order to have a suf-
ficiently high binding affinity toward a given macromolecular target. As a result, the
number of bioactive compounds is very small compared to a vast collection of candidate
compounds. The ZINC database of commercially available small molecule entities consists
of 17,900,742 drug-like compounds collected from 243 vendors as of January 2016 [49].
Considering molecules yet to be synthesized, the chemical universe comprises an estimated
novemdecillion (1060) of small organic compounds [50]. In the early stage of drug discov-
ery, this large number of candidates need to be downsized to hundreds or thousands of
the most promising compounds. Experimental high-throughput screening is a conventional
approach used by the pharmaceutical industry to identify bioactive molecules, however, it
suffers from high costs and relatively low hit rates [51]. For instance, a recent study by the
Tufts Center for the Study of Drug Development estimates that the development of a new
prescription medicine typically continues for longer than a decade with the total costs of
over 2.5 billion US dollars [52].
Rational drug design employs computational modeling to reduce the overall costs, im-
prove the efficiency and speed up the drug development time [53, 54]. Instead of experi-
mental high-throughput screening, candidate small molecules are virtually screened (VS)
by computational modeling before sending to experiment tests [55]. Current VS techniques
fall into two main categories: ligand-based similarity search and structure-based molecu-
lar docking [56]. Although the experimentally solved structures of target proteins are not
required in the ligand-based approach, an initial set of already developed drug molecules
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must be known. This information, however, is often missing, particularly for novel protein
targets. On the other hand, the advances in X-ray crystallography and nuclear magnetic
resonance constantly accumulate structures of biological molecules at atomic-level, which
foster structure-based drug discovery projects [57, 58].
1.3 Molecular docking
Structure-based molecular docking mainly utilizes the vast quantity of data in struc-
tural biology, where various methodologies in DISE can be applied to improve the state-
of-the-art.
Data in structural biology is captured in a distributed way through each individual
laboratory at research universities or institutes. X-ray crystallography [59] is currently the
mostly used technique for structure determination of biological macromolecules at atomic
resolution. A second method is nuclear magnetic resonance (NMR) [60]. NMR provides
data that are in many ways complementary to those obtained from X-ray crystallography
and thus widen our view of protein molecules. After the structure of the macromolecule is
determined, the information will be recorded in text formats, and then uploaded to data
centers for archiving. There are several mirror centers over the world, all under the name
of “Protein Data Bank”(PDB), including RCSB PDB and BMRB (Biological Magnetic
Resonance Data Bank) in the USA, PDBe in Europe, and PDBj in Japan. As the “Big
Data parking lots”, these PDB sites serve well. As the day of writing (October 2016),
a total of 123,273 entries about experimentally-determined structures of proteins, nucleic
acids, and complex assemblies are archived and publicly accessible at RCSB PDB, which
occupies over 555 GBbytes of disk usage [61]. Nevertheless, the functionality of “processing
workhorse” is missing in these data centers, which means that over 555 GBbytes of files
need to be transferred to perform any comprehensive analysis on the data. This missing
functionality is currently under the intensive development [62].
Building a molecular docking model can be tackled as training a supervised machine
learning model [63–66]. Specifically, the training dataset consists of a set of training ex-
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amples, and each example is a pair of an input object (known as the feature vector), and
a desired output value (known as the target value). A supervised learning algorithm ex-
amines the training data and yield a fitted function, which can be used for mapping new
examples. An optimal fitted function will determine the labels as accurate as possible for
even unseen instances [67]. In molecular docking, supervised learning algorithms take in
a large number of candidate ligands and their various conformations are evaluated by the
supervised learning algorithm, then report the label for each candidate ligand. The feature
vectors are the quantification of different nature (geometrical, physicochemical interactions,
pharmacophore) of protein-ligand complexes [63], while the target values are the predicted
conformation of the ligands and the corresponding binding affinity. In chapter 2 and 3, I
will discuss how to improve the supervised ML model for molecular docking by deploying
a more advanced target value as well as formulating a better feature vector.
Rational drug design often involves running molecular docking programs over a large
number of candidate ligands against the target protein. In this situation, assessing each
protein-ligand pair can be viewed as one independent task, and “embarrassing parallelism”
is very suitable. However, in order to achieve higher accuracy, more sophisticated molecular
docking models are emerging, which has a rising demand on the processing speed for
each docking task [68,69]. Therefore, conventional “embarrassing parallelism” needs to be
complemented with “serious parallelism” to meet the demand. In chapter 4, I will discuss
about how to achieve this goal in molecular docking using modern heterogeneous computing
platforms.
1.4 Guide to the chapters
This research work aims to improve the current methodologies in rational drug design
by (1) investigating into the two main aspects in supervised learning: target value and
the feature vector, and (2) implementing the methods on parallel computing architects to
power such data-intensive scientific calculations.
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In Chapter 2 Contact mode score, we superseded the conventional target value, RMSD,
with our newly developed Contact Mode Score (CMS), which addresses several issues with
RMSD. CMS mitigates the dependence on the ligand size, and can be applied to evaluate
flexible docking methods simulating receptor conformational changes upon ligand docking.
We further developed eXtended Contact Mode Score, or XCMS, which capitalizes on the
conservation of ligand binding across structurally similar pockets occupied by chemically
similar ligands. For instance, it can be used to systematically evaluate complex structures
constructed by virtual screening, where a retrospective assessment cannot be performed
because the experimental structures of the majority of complexes are unavailable.
In Chapter 3 GeauxDock engine, we feature engineered a hybrid model incorporat-
ing evolutionary related information as well as physics attributes of the target complex.
Benchmark calculations demonstrate that the model has a strong capacity to recognize
native-like binding modes. In addition, the model reveals that evolutionary information
can be effectively compensated by the increased contribution from physics-based attributes,
which successively help maintain the accuracy of the model at the low level of evolutionary
information. Therefore, our model is well suited for proteome-scale applications utilizing
increasingly growing data in structural biology.
In Chapter 4 GeauxDock computing, we implemented the GeauxDock model on het-
erogeneous computing platforms using a modular code framework, which supports modern
multi-core CPU, as well as Xeon Phi and GPU accelerators with significant speedup com-
pared with serial codes. In addtion to the evaluation of the computational performance,
we examined the energy consumption and hardware costs, and found that heterogeneous





Management guru and author Peter Drucker famously observed, “if you can’t measure
it, you can’t improve it”. Drucker means that you can’t know whether or not you are
successful unless success is defined and tracked. Only with a clearly established metric, one
can quantify progress and adjust the process to produce the desired outcome.
In an molecular docking simulation, the success is often measured using the root-
mean-square deviation (RMSD) [70]. Typically, predictions within an RMSD of 2 Å are
considered successful, whereas values higher than 3 Å indicate that the docking failures.
A standard RMSD function that quantifies the difference between two poses of the same






||ai − bi||2 (2.1)
where molecule poses A = a1, a2, ..., an and b1, b2, ..., bn are defined by sets of Cartesian
coordinates ai and bi of individual heavy (non-hydrogen) atoms. This formulation shows
that the RMSD is calculated based on a predefined one-to-one correspondence between
atoms in poses A and B. Although equivalent atoms can be found by matching atom
indices, the presence of symmetric functional groups may result in inflated RMSD val-
ues [71]. Several modified RMSD calculation methods were developed to handle symmetric
molecules [71, 72]. These techniques re-index atoms dynamically instead of using the pre-
defined order of atoms.
Further, a strong dependence of the RMSD on the number of atoms complicates the
assessment of molecules with different sizes [73, 74]. On the other hand, the development
and optimization of scoring functions for molecular docking often involves tuning force
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field parameters against diverse datasets of protein-ligand complexes. For example, weight
factors can be adjusted to maximize the capability to recognize near native conformations
amongst a large set of docking decoys [75–77]. An imprecise classification of near native
and decoy conformations, e.g. by using a fixed RMSD threshold, may lead to suboptimal
weight factors. Even though the number of ligand atoms can be taken into account by
calculating the statistical significance of RMSD values [73, 74], statistical testing is rarely
employed in the development and optimization of docking algorithms and scoring functions.
Another issue is that ligand RMSD does not account for the protein environment [78].
Depending on the ligand size and complexity, low RMSD values can be obtained even if
key interactions with the protein are absent. Conversely, a substantial deviation from the
experimental structure of a moiety that is irrelevant to binding (e.g., a solvent-exposed
group) can notably increase the RMSD even when crucial binding features are recovered
by docking calculations [79]. To address this problem, the relative displacement error
(RDE) [80] was developed. The RDE down-weights large deviations, therefore, it is less
sensitive to a small number of misplaced atoms compared to the RMSD. Nevertheless,
similar to RMSD, the RDE takes no account of the protein environment.
Although conventional docking methods employ a single, static structure of the re-
ceptor, more recent approaches incorporate protein flexibility by docking against protein
ensembles or using rotamer libraries for binding residue side chains [69, 81, 82]. The tradi-
tional ligand RMSD cannot be used to assess the accuracy of fully flexible molecular dock-
ing, where not only ligands, but also receptors change their internal conformations. For that
reason, an alternative measure based on real space R-factors was proposed to compare elec-
tron density rather than to calculate the RMSD from Cartesian coordinates [79]. Moreover,
predicted binding modes can be visually inspected in order to identify key protein-ligand
interactions recovered by docking calculations [78]. However, the lack of automation makes
this approach inapplicable to large datasets of docked ligand conformations.
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The calculation of RMSD is straightforward and has a low computational complexity,
therefore, it is still frequently used as the assessment measure, particularly across large
datasets of protein-ligand complexes. Nevertheless, new techniques are highly desired to
evaluate not only purely geometrical features, but also biological aspects of binding. On
that account, we developed the Contact Mode Score (CMS), which effectively quantifies the
similarity of ligand binding conformations. CMS compares the sets of interatomic contacts
formed by a ligand and its receptor rather than ligand Cartesian coordinates. Such an
approach also allows for the protein environment to be included in the assessment. Further,
we developed the eXtended Contact Mode Score (XCMS), which provides a convenient
template-based method to compare those protein-ligand complexes composed of different
proteins and non-identical ligands. In contrast to the RMSD, CMS and XCMS are less
dependent on the ligand size and have a well-defined statistical significance.
2.2 Materials and methods
2.2.1 Experimental Datasets
Three datasets of protein-ligand complexes are used in this study. The first dataset
was compiled from the eFindSite library [83] by clustering template proteins at 40% se-
quence identity using PISCES [84], and then selecting representative chains that non-
covalently bind small organic molecules at distinct locations. This procedure produced
a set of 14,059 non-redundant structures of protein-ligand complexes, referred to as the
eFindSite dataset, which was used to develop a mixed-resolution model of complex struc-
tures. In addition, we used the Astex/CCDC dataset [85] comprising the high-quality ex-
perimental structures of 201 pharmacologically relevant proteins co-crystalized with drug
molecules. The dependence of CMS and RMSD on the number of ligand atoms was exam-
ined against the Astex/CCDC dataset. Finally, the XCMS was developed and tested on the
BioLiP database [86]. BioLiP provides a comprehensive collection of protein-ligand com-
plex structures curated specifically for studies focusing on biologically relevant interactions
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and template-based modeling approaches. From the entire database comprising 94,887 lig-
ands bound to 71,359 proteins, we randomly selected 2,200 protein-ligand complexes as
query structures. In XCMS benchmarking, we searched the complete BioLiP database for
non-identical templates for each query structure. A complex was used as the template if the
Pocket Similarity score (PS-score) against the query pocket is <0.9, the fingerprint Tani-
moto coefficient (1D-TC) against the query ligand is >0.5, and the number of ligand heavy
atoms is greater than 6. Using these criteria produced a dataset of 802,058 query-template
pairs to benchmark the XCMS. The PS-score measures the structural similarity of two lig-
and binding sites; it ranges from 0 to 1 with higher values indicating higher similarity [87].
1D-TC employs 1024-bit molecular fingerprints to quantify the chemical similarity of two
small molecules. The calculations of 1D-TC were conducted with OpenBabel [88], which
supports fingerprint indexing to accelerate searches against large databases.
2.2.2 Simulated Datasets
In addition to experimental datasets, three sets of computer-generated structures were
compiled for benchmarking purposes. The first simulated dataset is based on Astex/C-
CDC [85] and it was prepared to assess the dependence of RMSD and CMS on the number of
ligand heavy atoms. A series of systematic perturbations were applied to co-crystalized lig-
ands, each comprising random translations and rotations about the x, y and z-axis of up to
0.02 and 5 deg, respectively. After each round of perturbation, RMSD and CMS were com-
puted against the native conformation of a ligand. The second simulated dataset contains
Metropolis Monte Carlo (MMC) trajectories constructed by GeauxDock [77] for Astex/C-
CDC complexes. GeauxDock employs a mixed-resolution representation of protein-ligand
complexes and a hybrid scoring function comprising physics-, evolution-based energy terms
and statistical potentials. By lowering the unitless pseudo energy calculated by the scoring
function, GeauxDock effectively finds the near native structures of protein-ligand complexes
by exploring low-energy configurations according to a dimensionless scoring function. Here,
binding ligands were initialized at random conformations and GeauxDock simulation en-
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gine [77] was used to generate docking trajectories through 800 MMC cycles. The CMS was
calculated for each accepted conformation against the ligand bound in the crystal complex
structure.
The last simulated dataset was built on BioLiP [86] to benchmark RMSD,CMS and
XCMS using predicted and random ligand conformations. First, query ligands were ran-
domized within receptor binding pockets to produce a set of 2,200 random conformations
of query ligands. Subsequently, each randomized ligand was re-docked to the protein with
AutoDock Vina [72]. The docking box was set to an optimal size based on the radius of
gyration of the ligand [89] and the binding pocket center was set to the geometric center of
the compound bound in the experimental complex. This procedure produced 2,200 docked
conformations of query ligands. For each simulated conformation, RMSD and CMS were
calculated against the experimental structure, whereas the XCMS was calculated using a
template. Similar to the experimental BioLiP dataset, we included only those templates
having more than 6 heavy atoms, a PS-score of <0.9, and a 1D-TC of >0.5. For the
template-based assessment with XCMS, suitable templates were identified for a subset of
695 targets.
2.2.3 Molecular Representation
Fast computation without compromising molecular details is achieved by describing
protein-ligand complex structures at a mixed-resolution. A heavy-atom representation is
used for ligands with the following chemical types according to SYBYL [90]: carbon sp
(C.1), carbon sp2 (C.2), carbon sp3 (C.3), aromatic carbon (C.ar), carbocation in gua-
dinium groups (C.cat), nitrogen sp (N.1), nitrogen sp2 (N.2), nitrogen sp3 (N.3), posi-
tively charged nitrogen sp3 (N.4), amide nitrogen (N.am), aromatic nitrogen (N.ar), trig-
onal planar nitrogen (N.pl3), oxygen sp2 (O.2), oxygen sp3 (O.3), oxygen in carboxylate
and phosphate groups (O.co2), phosphorous sp3 (P.3), sulfur sp2 (S.2), sulfur sp3 (S.3),
sulfoxide sulfur (S.O), sulfone sulfur (S.O2), and halogens (Br,Cl, F, I). Proteins are rep-
resented at the coarse-grained level. Proteins are represented at the coarsed-grained level.
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In CMS, two effective backbone points per residue are placed at the position of its Cα atom
(CA) and the geometrical center of the peptide plane (PP ). Small side chains of Ala, Asn,
Asp, Cys, Ile, Leu, Pro, Ser, Thr and Val are reduced to one pseudo atom located at the
geometric center, Leu, Pro, Ser, Thr and Val are reduced to one pseudo atom located at the
geometric center, whereas longer side chains of Arg, Gln, Glu, His, Lys, Met, Phe, Trp and
Tyr are described by two effective points corresponding to the middle of a virtual Cβ-Cγ
bond and the geometric center of the remaining side-chain atoms [91]. It is noteworthy
that this model is already implemented in a molecular docking program, GeauxDock [77].
In XCMS, two effective points per residue are used at the positions of its Cβ-Cγ atoms
(CA and CB, respectively), except for glycine that has only the CA atom.
2.2.4 Intermolecular Contacts
Contacts between ligand heavy atoms and protein effective points in the mixed-resolution
model are calculated using type-dependent distance thresholds. These threshold values were
optimized against the exact interatomic contacts extracted from high-resolution complex
structures in the eFindSite dataset, defined as pairs of heavy atoms within a distance of
4.5 Å. This cutoff is commonly used to determine the first hydration shell for proteins;
when solvent molecules are present within this shell, proteins atoms have less freedom
to interact with ligand atoms [92]. For each unique combination of a ligand atom type
l and an amino acid effective point type p, we found an optional distance, Dcntlp , that
reproduces high-resolution iteratomic contacts by maximizing the Matthews correlation
coefficient (MCC) [93]:
MCC =
TP × TN − FP × FN√
(TP + FP )(TP + FN)(TN + FN)(TN + FN)
(2.2)
Here, TP is the number of true positives, i.e. interatomic contacts that are correctly repro-
duced in the mixed-resolution model. TN is the number of true negatives, i.e. heavy atom
pairs farther away than 4.5 Å from each other in high-resolution structures and also above
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Figure 2.1: Calculation of the Contact Mode Score (CMS). First, intermolecular contacts
calculated between ligand atoms L and protein effective points P are stored in binary ma-
trices (1 - contact, 0 - no contact). Contact matrices for two arbitrary ligand conformations
are shown in A and C, whereas B is a contact matrix constructed for the reference confor-
mation. Next, a confusion table is computed for a pair of contact matrices; tables D and
E are calculated for pairs A-B and C-B, respectively. Finally, CMS is calculated as the
Matthews correlation coefficient for a given confusion table.
the corresponding type-dependent distance threshold for ligand atoms and protein effective
points in the mixed-resolution model. FP and FN are the numbers of false positives and
false negatives, respectively, i.e. those contacts that are over- and underestimated by using
the mixed-resolution description. Note that ligand atoms in our model are treated equally
when counting interatomic contacts. Although some methods prioritize certain parts of the
ligand to better capture important aspects of binding [78], these approaches largely depend
on manual inspection and thus cannot be automated.
2.2.5 Contact Mode Score
Essentially, the CMS quantifies the overlap of interatomic contacts in protein-ligand
complex structures. Figure 2.1 illustrates a procedure to calculate the CMS for three
conformations of a simplified system, in which the ligand has 3 heavy atoms (L1 − L3)
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and the protein has 4 effective points (P1 − P4). The first step is to construct the Global
Contact Matrix (GCM) encoding the interaction pattern for a particular ligand binding
conformation (Figure 2.1A - 2.1C). Here, the distance between each ligand atom L of type
l and each protein point P of type p is compared with the Dcntlp threshold to determine
whether L and P are in contact. The corresponding entry in the GCM matrix is set to 1
if the distance is below Dcntlp , otherwise it is set to 0. Next, a confusion matrix is generated
for a pair of GCMs, where one GCM represents a query (Figures 2.1A and 2.1C) and
the other is the reference (Figure 2.1B). Confusion matrices consist of the numbers of true
positives (TP ), true negatives (TN), false positives (FP ), and false negatives (FN). TP
are interatomic contacts that are present in both conformations and TN are pairs of ligand
atoms and protein effective points not in contact in both conformations. FP and FN are
over- and under-predicted contacts in the query conformation. Finally, Eq. 2.2 is used to
calculate the CMS whose values range from -1 to 1, with greater values indicating a higher
similarity between two conformations. Since relative distances between interacting points
are used in CMS calculations, the resulting similarity score is independent of the absolute
coordinate frames of query and reference structures. Furthermore, CMS correctly handles
any degrees of freedom associated with the molecular flexibility, therefore, it can be applied
to evaluate complex structures generated by ensemble docking and flexible receptor docking
protocols.
2.2.6 eXtended Contact Mode Score
CMS requires a predefined one-to-one atomic correspondence, therefore, it can be used
to measure the similarity of different conformations of the same protein-ligand pair. In
order to compare non-identical complexes formed by different proteins and ligands, we
developed the eXtended Contact Mode Score. In XCMS, equivalent atoms in two different
ligand molecules are identified with the kcombu program [94]. Kcombu implements a fast
and accurate build-up algorithm to perform chemical structure alignments and reports
the similarity between ligands in terms of the topological Tanimoto coefficient (2D-TC).
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Figure 2.2: Calculation of the eXtended Contact Mode Score (XCMS). First, Cartesian
distances calculated between ligand atoms L and protein effective points P are stored in
distance matrices. Matrices for two arbitrary ligand conformations are shown in A and
C, whereas B is a distance matrix for the reference conformation (distances are given in
Å). Next, two matrices are converted to distance vectors whose elements correspond to
pairs of protein effective points and ligand atoms (P : L). Finally, XCMS is computed as
Spearmans rank correlation coefficient for a given set of vectors.
Further, the local structure alignment algorithm APoc [87] is employed to match ligand-
binding pockets in a given pair of proteins in order to find equivalent residues. APoc
uses the geometrical and physicochemical features of binding sites and provides a PS-
score value, which measures the local similarity of ligand binding sites. Since equivalent
residues reported by APoc for two proteins may have different types, we use a Cα-Cβ
coarse-grained model in XCMS. Moreover, XCMS employs Local Contact Matrices (LCMs)
because alignments generated by APoc are local, covering only ligand binding sites.
XCMS calculations are illustrated in Figure 2.2. Three non-identical complexes are
shown in Figures 2.2A-2.2C. L1-L3 represent ligand heavy atoms matched by kcombu, so
that an atom L1 in the first complex is equivalent to L1 atoms in the second and third
complexes and so on. Protein residues are classified as ligand binding if any ligand atom
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is found within a distance of 7 Å from any protein atom. This distance was selected to
ensure that a sufficient number of binding residues are used for local alignments with APoc.
Protein residues matched by APoc are stored in the LCM as rows arranged according to
the pocket alignment. LCM entries are the distances between ligand atoms L and protein
effective points P corresponding to the CA and CB atoms of binding residues. Next,
LCMs are unrolled into 1D vectors maintaining the order of P : L pairs (Figures 2.2D
and 2.2E). The XCMS is then calculated as non-parametric Spearmans rank correlation
coefficient between two vectors [95].
Similar to the CMS, XCMS ranges from -1 to 1 with higher values indicating a higher
similarity between two conformations. However, in contrast to the CMS calculated from
a 4×4 confusion matrix, XCMS depends on the length of distance vectors. Therefore,
XCMS values are assigned a statistical significance under a null hypothesis that XCMS is
zero for a pair of randomly generated LCMs; the alternative hypothesis is that two LCMs
are significantly similar. The one-sided p-value is computed using the scipy package [96]
based on the Fisher transformation method [97]. Given a positive XCMS, lower p-values
indicate a higher statistical significance of the conformational similarity of protein-ligand
complexes.
2.3 Results and discussion
2.3.1 Mixed-Resolution Contacts
Many all-atom models define interatomic contacts using a distance threshold of 4.5
Å corresponding to the second solvation shell [92]. In the mixed-resolution model used to
calculate the CMS, type-dependent distance thresholds are optimized against the eFindSite
dataset of protein-ligand complexes to reproduce all-atom contacts. Figure 2.3A shows the
distribution of 720 (24 types of ligand atoms 30 types of protein effective points) contact
distances, Dcntlp . The majority of contact distances fall within a range of 4-6 Å. Those
effective points comprising more protein atoms, e.g. the side chains of Trp-2, Arg-2 and
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Figure 2.3: Parameterization of mixed-resolution intermolecular contacts. The distribution
of (A) contact distance thresholds Dcntlp and (B) the Matthews correlation coefficient (MCC)
values calculated vs. exact interatomic contacts across the eFindSite dataset.
Tyr-2, typically have larger Dcntlp thresholds than small amino acids, such as Ala-1, Ser-1
and Cys-1, as well as Cβ-Cγ virtual bonds and backbone CA and PP groups. In general,
optimized distance thresholds in the mixed-resolution model reliably reproduce the exact
interatomic contacts. As shown in Figure 2.3B, MCC values for most interacting pairs are
larger than 0.5 with an average MCC of 0.7. Such accuracy in calculating intermolecular
contacts in the mixed-resolution model is sufficient to develop a contact-based similarity
measure.
2.3.2 Ligand Size Dependence of RMSD and CMS
The dependence of RMSD and CMS values on the ligand size was evaluated in a
perturbation experiment. Table 2.1 shows the average RMSD and CMS after the first
round of perturbation for Astex/CCDC complexes grouped based on the number of ligand
heavy atoms. Both CMS and RMSD show some dependence on the ligand size because
small ligands yield lower RMSD and higher CMS values compared with larger molecules.
In Figure 2.4A, we plot similarity (CMS, light gray circles) and dissimilarity (RMSD, dark
gray squares) values against the ligand size. The dependence of the (dis)similarity on the
ligand size is assessed by the Pearson correlation coefficient (PCC) [98]. The PCC is 0.850
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Table 2.1: Dependence of RMSD and CMS on the ligand size. Ligand conformations from
the Astex/CCDC dataset were subjected to one round of perturbation comprising a set
of forward translations and clockwise rotations. The mean values of RMSD and CMS are
reported for each size range.






for the RMSD and 0.780 for the CMS. In addition, we estimate the Mutual Information
(MI) between the RMSD and CMS, and the ligand size. It has been shown that the MI can
quantify the strength of a statistical association without bias for relationships of a specific
form with higher MI value indicating a stronger association [99]. The MI against the ligand
size is 0.714 for the RMSD and 0.512 for the CMS. Overall, the absolute values of PCC and
MI are lower for CMS, indicating that it is less dependent on the ligand size than RMSD.
Next, we performed five rounds of perturbation of ligands in the Astex/CCDC dataset.
Table 2.2 reports 25, 50 and 75 percentiles of RMSD and CMS as well as the quartile
coefficient of dispersion (QCD) [100] after each perturbation round. The percentile values
are also plotted in Figure 2.4B for the CMS and Figure 2.4C for the RMSD. Higher QCD
values indicate larger fluctuations of a given measure. Although the QCD for the CMS
increases with the number of perturbation rounds, it is systematically smaller than that
for the RMSD demonstrating that the CMS is more stable.
2.3.3 Examples of CMS Calculations
The CMS is a convenient measure not only to assess docking accuracy, but also to
analyze docking trajectories and the quality of scoring functions. On that account, we gen-
erated MMC trajectories for the Astex/CCDC dataset using GeauxDock [77] and calculated
CMS values against the experimental structure for the accepted configurations. Two exam-
ples are shown in Figure 2.5, aspartyl proteinase penicillopepsin complexed with a pepstatin
analogue (PDB-ID: 1apt, chain A, Figure 2.5A and 2.5B) [101] and and urokinase-type
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Table 2.2: Changes in RMSD and CMS in the perturbation experiment. Ligand confor-
mations from the Astex/CCDC dataset were subjected to multiple rounds of perturbation,
each comprising a set of forward translations and clockwise rotations. 25, 50, and 75 per-
centiles as well as the quartile coefficient of dispersion (QCD) calculated across the dataset




25% 50% 75% QCD 25% 50% 75% QCD
1 0.738 0.793 0.837 0.063 0.708 0.839 1.001 0.171
2 0.605 0.673 0.734 0.096 1.175 1.368 1.613 0.157
3 0.503 0.561 0.638 0.118 1.599 1.876 2.237 0.166
4 0.415 0.485 0.564 0.152 2.018 2.387 2.808 0.164
5 0.357 0.426 0.493 0.161 2.489 2.872 3.394 0.154
plasminogen activator complexed with an inhibitor (PDB-ID: 1c5x, chain B, Figure 2.5C
and 2.5D) [102]. Figure 2.5A and 2.5C show that at the beginning of docking simulations,
pseudo-energies are high and CMS values are low suggesting that initial ligands are far away
from experimental binding poses. Blue lines in both plots show that MMC simulations in
GeauxDock are driven by the pseudo-energy to reach low-energy states. Encouragingly,
the CMS increases as the pseudo-energy gradually decreases indicating that ligands are
moving toward native-like conformations. This correlation between the pseudo-energy and
the native-likeness is a desired characteristic of a scoring function, which is shown as scatter
plots in Figure 2.5B and 2.5D. It is noteworthy that our previous benchmarks of GeauxDock
demonstrated that the pseudo-energy and CMS are correlated for about three-quarters of
Astex/CCDC complexes [77].
Three representative snapshots selected from each docking trajectory are shown in Fig-
ure 2.6. These binding poses shown in blue were generated at the beginning (Figures 2.6A
and 2.6D), in the middle (Figures 2.6B and 2.6E), and at the end (Figures 2.6C and 2.6F)
of GeauxDock simulations. The corresponding CMS values calculated against experimen-
tal complex structures shown in orange are 0.286, 0.366 and 0.601 for penicillopepsin, and
0.424, 0.583 and 0.771 for plasminogen activator, respectively. It is clear that high CMS
values correspond to docking conformations that are close to experimental structures, thus
the CMS is a good indicator of the native-likeness.
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Figure 2.4: Comparison of RMSD and CMS in the perturbation experiment. (A) Scatter
plot of RMSD (dark gray squares) and CMS (light gray circles) vs. the number of ligand
atoms after a single perturbation round. Boxplots of (B) CMS and (C) RMSD calculated
for ligand conformations generated through multiple perturbation rounds. Boxes end at
the 25 and 75 percentiles, a horizontal line in a box is the 50 percentile (median).
2.3.4 Algorithm Complexity of CMS and RMSD
We compare the time to calculate CMS and RMSD using the Astex/CCDC dataset.
Specifically, for each complex, CMS and RMSD values for 8 variational conformations
were calculated against the experimental structure, resulting in 1 632 (2048) individual
calculations. Using one thread on a 2.6 GHz Sandy Bridge Xeon 64-bit processor, the wall
time to finish RMSD (CMS) calculations is 17 s (5 389 s), thus computing RMSD is about
317 times faster than CMS. The reason for a longer wall time required to calculate CMS
is that it considers a protein environment and iterates over all pairs of ligand atoms and
protein points, whereas the RMSD iterates only over ligand atoms. From the perspective of
algorithm complexity, the CMS calculation is O(P×L) and the RMSD calculation is O(L),
where P and L are the total number of protein points and ligand atoms, respectively.
Although both RMSD and CMS calculations are based on Euclidean distances,
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Figure 2.5: Analysis of docking trajectories with the CMS. Docking simulations were
conducted using GeauxDock for (A, B) penicillopepsin/pepstatin analogue (PDB-ID: 1apt,
chain A) and (C, D) plasminogen activator/inhibitor (PDB-ID: 1c5x, chain B). (A, C)
Metropolis Monte Carlo trajectories for CMS (green) and pseudo-energy (E, blue). (B, D)
Scatter plots of CMS vs. the pseudo-energy; each dot represents an accepted protein-ligand
conformation.
CMS requires a longer computing time due to the relatively large number of 838 effective
points per protein on average.
2.3.5 Dependence of XCMS on the Ligand and Pocket Similarity
XCMS was developed as an extension of the CMS to measure the similarity of ligand
binding conformations among complexes formed by different proteins and ligands. In order
to establish when a similar ligand binding conformation can be expected, we investigate
the dependence of XCMS on the pocket and ligand similarity in experimental complex
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Figure 2.6: Examples of docking poses from GeauxDock simulations. (A-C) penicil-
lopepsin/pepstatin analogue (PDB-ID: 1apt, chain A) and (D-F) plasminogen activator/in-
hibitor (PDB-ID: 1c5x, chain B). Three docking poses are shown in blue for each system,
(A, D) initial, (B, E) intermediate, and (C, F) final conformations. The corresponding
experimental complex structures are colored in orange.
structures. Specifically, XCMS, PS-score and 2D-TC values were calculated for all query-
template pairs across the BioLiP database. Heat maps in Figure 7 were constructed by
dividing query-template pairs into 400 groups based on 2D-TC and PS-score values and
then averaging XCMS and p-value within each group. Note that those pairs having a PS-
score between the query and the template of >0.9 were excluded in order to examine only
non-identical systems. As expected, Figure 2.7A demonstrates that the conformational
similarity of protein-ligand complexes captured by XCMS increases as their pockets and
binding ligands become more similar. Figure 2.7B shows the statistical significance of
query-template XCMS as a function of PS-score and 2D-TC. The significance of XCMS
increases with the increasing similarity of ligands and binding pockets in query and template
structures. A clear boundary in Figures 2.7A and 2.7B at a PS-score of 0.4 corresponds to
a threshold separating statistically similar and dissimilar binding pockets in proteins [87].
Overall, these results corroborate previous studies reporting the conservation of ligand
binding across structurally similar pockets occupied by chemically similar ligands [76,103–
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Figure 2.7: XCMS and its statistical significance for the BioLiP dataset. Query-template
pairs are grouped based on the similarity between their ligands (measured by the 2D
Tanimoto coefficient) and pockets (measured by PS-score). Heat maps of (A) the arithmetic
mean values of XCMS and (B) the geometric mean of the p-value for positive XCMS.
105]. It is important to note that both pocket similarity and ligand similarity should be
taken into account when selecting a template to calculate XCMS. In practice, we first rank
templates by the product of 2D-TC and PS-score and then take the top-ranked structure
to assess the target conformation using XCMS.
2.3.6 Large-Scale Benchmarking of Molecular Docking
Molecular docking with AutoDock Vina was performed for a subset of 2,200 query
complexes selected the BioLiP dataset. In Figure 2.8, we first use this simulated dataset
to investigate the relationship between RMSD, CMS and XCMS. Here, the strength of
association is measured with the maximal information coefficient (MIC) [106]. The MIC
belongs to the maximal information-based nonparametric exploration class of statistics and
quantifies linear and non-linear associations by applying mutual information to continuous
random variables. Figure 2.8A shows the correlation between CMS and RMSD, both of
which are calculated against the experimental structures of query complexes; the MIC
between the CMS and RMSD is as high as 0.91. Figure 2.8B shows the correlation between
CMS and XCMS, where the XMCS is calculated using template structures. Encouragingly,
these two contact-based measures are also highly correlated with a MIC of 0.88. Both MIC
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Figure 2.8: Correlation between RMSD, CMS, and XCMS. Docking conformations gen-
erated for the BioLiP dataset by AutoDock Vina are used to calculate RMSD and CMS
against experimental binding poses. XCMS was computed against a holo template selected
from the BioLiP database based on the highest value of the product of PS-score and the
2D Tanimoto coefficient. Scatter plots of (A) CMS vs. RMSD and (B) CMS vs. XCMS.
values are statistically significant at p-value of < 1.28×10−6 [106] demonstrating a strong
association between RMSD, CMS and XCMS.
Next, we use the RMSD, CMS and XCMS to evaluate the accuracy of molecular docking
for the BioLiP dataset. In Figure 2.9 and Table 2.3, docking poses generated by AutoDock
Vina are compared to random ligand conformations generated within receptor binding
pockets. Regardless of the evaluation metric, Vina constructed native-like conformations
for a significant number of complexes, whereas the vast majority of random conformations
are far away from experimental structures. For instance, the median (50% quartile) RMSD,
CMS, and XCMS for Vina is 2.89 Å, 0.574, and 0.694, respectively, compared to 7.60 Å,
0.152, and 0.198 for random conformations. Overall, these results demonstrate that when
suitable templates can be identified in the BioLiP database, a retrospective assessment with
RMSD and CMS against experimental structures can be replaced with a template-based
evaluation using the XCMS.
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Figure 2.9: Assessment of docked and randomized ligand conformations across the Bi-
oLiP dataset. The similarity to experimental binding poses is assessed with (A) RMSD,
(B) CMS, and (C) XCMS. RMSD and CMS were calculated against experimental com-
plex structures. XCMS was calculated against a holo template selected from the BioLiP
database based on the highest value of the product of PS-score and the 2D Tanimoto co-
efficient. Dark gray violins correspond to ligands docked by AutoDock Vina, whereas light
gray violins are calculated for randomized ligand conformations. Black horizontal lines are
median values.
2.3.7 Examples of XCMS Calculations
Finally, we discuss two representative examples illustrating how XCMS can be used to
evaluate docking conformations, mitogen-activated protein kinase 14 (MAPK14, PDB-ID:
2yiw, ligand: YIW, chain: A) [107] and ribose-5-phosphate isomerase (RpiA, PDB-ID:
1o8b, ligand: ABF, chain A) [108]. Both query ligands (YIW and ABF) were docked into
their target binding pockets by AutoDock Vina [72] starting from random conformations.
We first calculated the RMSD and CMS against native complexes to evaluate the dock-
ing accuracy. Table 2.4 shows that docking simulations were successful in both cases and
the predicted conformations are highly similar to experimental structures; for instance,
the RMSD is 0.42 Å and the CMS is 0.94 for MAPK14. Next, we evaluate docking con-
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Table 2.3: Assessment of docked and randomized ligand conformations across the BioLiP
dataset. RMSD and CMS were calculated against experimental complex structures. XCMS
was calculated against a holo template selected from the BioLiP database based on the
highest value of the product of PS-score and 2D Tanimoto coefficient. Mean values as well
as 25%, 50% and 75% quartiles are reported.
Statistic
AutoDock Vina Random
RMSD[Å] CMS XCMS RMSD[Å] CMS XCMS
mean 3.66 0.548 0.545 8.03 0.191 0.194
25% 1.4 0.308 0.203 5.49 0.07 0.036
50% 2.89 0.574 0.694 7.6 0.152 0.198
75% 5.29 0.798 0.912 10.02 0.279 0.366
formations with the XCMS. Proto-oncogene tyrosine-protein kinase Src (c-Src, PDB-ID:
3f3u, ligand: 1AW, chain A) [109] was selected from the BioLiP database as a template for
MAPK14, whereas central glycolytic gene regulator (CggR, PDB-ID: 3bxh, ligand: F6P,
chain A) [110] was selected as a template for RpiA. XCMS values calculated against tem-
plate complexes reported in Table 2.4 demonstrate that the template-based assessment is
consistent with the direct evaluation using CMS and RMSD; for instance, the XCMS is
0.96 with a highly significant p-value of close to 0 for MAPK14.
Table 2.4 also includes various similarity scores for query-template pairs as well as
their functional classification. MAPK14 and c-Src belong to the same class of transferase
enzymes transferring phosphorus-containing groups (Enzyme Commission, EC number 2.7.-
.-) and have globally similar structures with a Template Modeling score (TM-score) of 0.76.
TM-score is a length-independent measure of the structural similarity between proteins
[111]; it ranges from 0 to 1, with values 0.4 and higher indicating a statistically significant
similarity. In contrast, RpiA and CggR have unrelated structures with a TM-score of
0.27. RpiA is an enzyme, ribose-5-phosphate isomerase (EC number 5.3.1.6), whereas non-
enzyme CggR belongs to the SorC/DeoR family of prokaryotic transcriptional regulators.
In both cases, template-bound ligands are similar to query ligands with a 2D-TC of 0.41
for MAPK14/c-Src and 0.88 for RpiA/CggR. In order to visually compare ligand binding
conformations, global and local structure alignments constructed for MAPK14/c-Src and
30
Table 2.4: Assessment of ligand binding poses docked by AutoDock Vina. Two case studies
are presented, MAPK14 complexed with triazolopyridine inhibitor (PDB-ID: 2yiw, ligand
YIW, chain A) and ribose-5-phosphate isomerase complexed with the inhibitor arabinose-
5-phosphate (PDB-ID: 1o8b, ligand ABF, chain A).
Metric/info
Case study
2YIW YIW A 1O8B ABF A




Template 3F3U 1AW A 3BXH F6P A
TM-scorea 0.76 0.27
PS-scoreb 0.7 0.46
p-value of PS-score 6.28E-09 4.90E-05
2D-TCc 0.41 0.88
Query EC# 2.7.11.24 5.3.1.6
Template EC# 2.7.10.2 Non-enzyme
XCMS 0.96 0.76
p-value of XCMS 0 1.56E-63
RpiA/CggR are shown in Figure 10. Ligands bound to MAPK14 and c-Src adopt a similar
conformation when protein structures are superposed according to the global alignment
by Fr-TM-align [112] (Figure 2.10A) and the local alignment by Apoc [87] (Figure 2.10B).
Since the global structure alignment between RpiA and CggR is random, it cannot be used
to provide equivalent residues for XCMS calculations (Figure 2.10C). Nonetheless, APoc
constructed a statistically significant local alignment of binding pockets in RpiA and CggR
with a PS-score of 0.46 and the corresponding p-value of 4.9×10−5. When protein structures
are superposed according to the local alignment, binding ligands in RpiA and CggR adopt
a similar conformation (Figure 2.10D). These examples demonstrate that although XCMS
calculations do not require globally similar templates, the chemical similarity of bound
ligands as well as the similarity of binding sites in query and template structures should
be high enough to ensure a meaningful template-based assessment.
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2.4 Conclusions
The Contact Mode Score, or CMS, was developed in this study to quantify the con-
formational similarity of protein-ligand complexes based on intermolecular contacts. Its
major advantages over the traditional root-mean-square deviation include less dependency
on the ligand size and taking into account the protein environment. Consequently, the
CMS can be used to measure the ligand binding similarity across diverse protein-ligand
datasets as well as to evaluate flexible docking methods simulating receptor conforma-
tional changes upon ligand binding. In order to effectively compare binding poses of
non-identical ligands bound to different proteins, we further developed the eXtended Con-
tact Mode Score, or XCMS. The XCMS capitalizes on the conservation of ligand bind-
ing across structurally similar pockets occupied by chemically similar ligands. For in-
stance, it can be used to systematically evaluate complex structures constructed by vir-
tual screening, where a retrospective assessment cannot be performed because the exper-
imental structures of the majority of complexes are unavailable. CMS and XCMS are
freely available at http://brylinski.cct.lsu.edu/content/contact-mode-score and
http://geaux-computational-bio.github.io/contact-mode-score/.
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Figure 2.10: Examples of the superposition of query and template structures. The query
protein is ice blue with its binding residues marked by red dots and the bound ligand shown
as red sticks. The template protein is cyan with its binding residues marked by green
dots and the bound ligand shown as green sticks. (A, B) The superposition of MAPK14
(PDB-ID: 2yiw, chain A) and c-Src (PDB-ID: 3f3u, chain A). (C, D) The superposition of
ribose-5-phosphate isomerase (PDB-ID: 1o8b, chain A) and central glycolytic gene regulator
(PDB-ID: 3bxh, chain A). For each pair, two superpositions are shown, (A, C) the global





Computational identification of potential leads against a specific protein target is of
paramount importance to modern drug design. As of April 2015, the ZINC database of
commercially available small molecule entities for drug discovery contains 17,900,742 drug-
like compounds collected from the catalogs of 236 vendors [49]. At the outset of drug
development, this vast number of compounds must be downsized to typically hundreds to
thousands of the most promising candidate molecules. High-throughput screening (HTS)
often adopted by the pharmaceutical industry is a conventional approach for lead identi-
fication, however, it suffers from high costs and low hit rates. Conversely, computational
methods such as virtual screening (VS) provide faster and cheaper alternatives to HTS with
many successful examples described in the literature [113–115]. Current VS techniques fall
into two main categories: ligand-based similarity searching and structure-based molecular
docking [56]. Although the experimentally solved structures of target proteins are not re-
quired in the ligand-based approach, an initial set of already developed compounds must
be known. However, this information is often unavailable, particularly for novel molecular
targets. In contrast, the advances in X-ray crystallography and nuclear magnetic reso-
nance result in the accumulation of atomic-level structures of biological molecules fostering
docking-based drug discovery projects [57,58].
A typical molecular docking program incorporates two important components, the
prediction of the binding mode of a drug candidate within the target pocket and the es-
timation of binding affinity from molecular interactions. Most currently available docking
approaches implement effective algorithms to predict near-native binding modes [116–119],
however, noticeable differences still exist when compared with the experimental data. For
instance, a recent study evaluated seven popular docking programs on a dataset of 1300
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complexes showing a wide range of the average root-mean-square-deviation (RMSD) values
from 2.7 Å to 4.5 Å [120]. In addition to binding mode prediction, a scoring function is
another pivotal component of molecular docking that guides the exploration of the confor-
mational space and estimates the binding affinity for putative binding modes. Many scor-
ing functions developed to date [121–126] can be broadly categorized into three classes,
force field-based, empirical, and knowledge-based [127–129]. Recently, Liu and Wang pro-
posed a new type of scoring function called descriptor-based or machine learning-based to
capture the new trend in this field [130]. Methods using descriptor-based scoring functions
encode the properties of ligands and proteins as well as protein-ligand interactions into sets
of descriptors followed by applying machine learning to compute protein-ligand binding
scores [130]. Notwithstanding the progress in the development of scoring functions for lig-
and docking, several comparative studies reported that no single algorithm systematically
outperforms other methods across all protein targets [116,131,132].
In general, high-resolution protein structures are required for satisfactory results from
molecular docking regardless of which scoring function is used [133]. Additionally, the pre-
diction success rate drops from the ligand-bound to ligand-free conformational state of a
target protein [134]. This is due to the fact that many proteins undergo structural changes
in functionally relevant regions on ligand binding [135]. It has been demonstrated that even
minor changes affect the docking accuracy; for example, the mean protein rearrangement
greater than 1.5 Å may cause a loss of 90% of the initial docking accuracy [136]. Although
high-resolution structures are usually preferred in docking simulations, these may not be
available in the near future for many pharmacologically important drug targets such as
membrane spanning G-protein coupled receptors and ion channels [137]. Conversely, Skol-
nick et al. pointed out that high-resolution structures may actually conceal the inherent
structural plasticity of ligand binding regions [138]. For instance, the structural varia-
tion of a highly conserved ATP-binding site is about 2.4 Å, as measured over a subset of
inhibitor-bound crystal structures of protein kinases [139]. To address this issue, a recently
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developed ligand homology modeling (LHM) approach [] integrates structural information
extracted from evolutionarily related proteins into the modeling of protein-ligand interac-
tions to improve the tolerance to distortions in target binding sites. LHM was one of the
first approaches to successfully incorporate evolutionary information in ligand docking and
VS [76]. Q−DockLHM further exploited the ideas of LHM by implementing a descriptor-
based scoring function. Nevertheless, an open questions is how evolutionary descriptors
supplement physics-based components in a force field that combines these two classes of
scoring terms.
In this study, we describe the development and benchmarking of GeauxDock, a new ap-
proach for ligand molecular docking. GeauxDock uses a descriptor-based scoring function
integrating evolutionary constraints with statistical potentials and physics-based energy
terms. Moreover, it features a mixed-resolution molecular representation of protein-ligand
complex structures at the level of ligand heavy atoms and pro- tein effective points. A
Monte Carlo protocol is used to efficiently sample the conformational space with the flex-
ibility of ligand and receptor molecules modeled using an ensemble- based approach. The
scoring function in GeauxDock was parameterized on a large dataset of protein-ligand com-
plexes and further optimized to produce a correlation between the total pseudoenergy and
the native-likeness of binding poses. Finally, we carry out an analysis of the contribution
of various scoring terms to the identification of final docking conformations. We demon-
strate that although evolutionary constraints generally improve the docking accuracy, the
scarcity of this information can be effectively compensated by increasing the contribution
from physics-based energy components.
3.2 Materials and methods
3.2.1 Datasets
Two datasets of protein-ligand complexes are used in this study. The first set was
compiled from the eFinedSite library [83] by clustering template proteins at 40% sequence
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identity using PISCES [84] and then selecting representative chains that noncovalently bind
small organic molecules at distinct locations. This procedure resulted in 14,059 nonredun-
dant structures of protein-ligand complexes, referred to as the eFindSite protein Data Bank
(PDB) [140] dataset, that are used to derive potentials and parameters for the docking force
field. The second dataset comprises 201 high-quality crystal structures taken from the As-
tex/CCDC collection of pharmacologically relevant drug targets complexed with ligand
molecules [85]. As our force field includes potentials calculated from evolutionarily related
binding pockets, we selected those proteins for which eFindSite predicted the binding site
within a distance of 8 Å from the geometric center of a ligand in the experimental complex
structure. eFindSite is a threading/structure-based method that detects conserved binding
sites accross sets of homologous proteins [83]. For each target, we ran eFindSite at two
different thresholds for the maximum target-template sequence identity, 80 and 40%. The
first protocal uses both close and remote homologs to detect functional sites, whereas the
second uses only those templates that are evolutionarily weakly related to the target. The
Astex/CCDC dataset is used for the force field optimization and benchmarking.
3.2.2 Molecular representation of complex structures
GeauxDock uses the same molecular representation as in the section 2.2.3.
3.2.3 Force field for molecular docking
Protein-ligand complexes are stabilized by a variety of molecular interactions. Here,
we developed a new descriptor-based force field for the modeling of protein-ligand interac-
tions that combines classical physics-based potentials with statistical and knowledge-based
scoring terms. Specifically, we include the following nine energy terms: (i) electrostatic
and (ii) van der Waals interactions, (iii) hydrogen bonds, (iv) hydrophobic interactions, (v)
generic and (vi) pocket-specific contact potentials, (vii) a pseudopharmacophore potential,
and position restraints on (viii) family conserved anchor substructures, and (ix) the binding
site center.
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Electronic and van der Waals interactions (i, ii). Because of the mixed-resolution
model, we use soft electrostatic, P softele , and soft Lennard-Jones, P
soft
vdW , potentials [141].
Electrostatic interactions are described by:
P softele (l, p) = qlqpg(rlp) (3.1)
Let rlp be the distance between the l
th ligand atom and the pth protein effective point
with the corresponding partial charges ql and qp. Then g(rlp) = 1/Rlp for Rlp≥1, and




lp for Rlp < 1, where Rlp = srlp, a = 4 − 3k and b = 2k − 3. k
is an adjustable parameter that controls the value of the electrostatic potential at zero
separation and it is set to 2.0, and s is a scaling factor set to 0.5. Partial charges on
ligand atoms are calculated using the Mulliken population analysis [142] implemented in
Open Babel [88], whereas those on proten effective points are assigned by adding partial
charges from the constituent atoms according to the Assisted Model Building with Energy
Refinement (AMBER) ff03ua force field [143].
The electrostatic interaction score, Esoftele , is a sum of P
soft
cle values taken over L×P









P softele (l, p) (3.2)
Van der Waals interactions are modeled using the following form of a soft Lennard-
Jones potential:












where r∗lp depends on both a ligand atom type and the amino acid effective point and it is
defined as r∗lp = κD
cnt
lp . ε is the depth of the potential well, and rlp is the distance between
the lth ligand atom and the pth protein point. The parameter α controls the value of the
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function at rlp = 0, and the parameter β controls the rate at which the function
approaches the maximum value at zero separation.
Type-dependent parameter ε are derived from the eFindSite/PDB dataset as follows:




where nlp is the observed number of contacts between a given pair of a ligand atom type
and the amino acid effective point, and n0lp is an expected number of contacts assuming no
specificity. The latter is defined as n0lp = Nχlχp, with the total number of N protein-ligand
contacts, and χl and χp corresponding to the mole fractions of ligand atoms of type l and
protein points of type p, respectively.
Parameters α, β and κ are optimized empirically on the eFindSite/PDB dataset by




P natvdW (l, p)−
〈




where the summation runs over D pairs of ligand atoms and protein points that are in
contact according to the mixed-resolution models of dataset complexes, P natvdW is the value
of the soft Lennard-Johns potential, P softvdW , for a given pair of the lth ligand atom
and the pth protein point. < P decvdW (l, p) > is the value of P
soft
vdW averaged over a set of 10
“decoy” distances rlp randomly generated around the interaction threshold D
cnt
lp , and δ is
the corresponding standard deviation. The optimal values of α = 0.88, β = 0.74, and
κ = 0.70 were found using the evolutionary search strategy [144].
For a given protein-ligand complex, the van der Waals interaction score, EsoftvdW , is
calculated by summing P softvdW values over all ligand atoms and protein effective points, and
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P softvdW (l, p) (3.6)
Hydrogen bonds (iii). The hydrogen bond potential, PHB, only applies to those atom
pairs that can form hydrogen bonds and it is modeled using single Gaussian restraints:






where rHBlp is the distance between the l
th ligand atom and the pth protein effective point,
and µHBlp is the average hydrogen bond length between ligand atoms of the same type as
l and protein points of the same type as p across the eFindSite/PDB dataset, with the
corresponding standard deviation σHBlp .
For a given protein-ligand complex, its hydrogen bond score is calculated by summing
PHB over those pairs of ligand atoms and protein effective points that can form hydrogen








PHB(l, p), if (l,p) can form a hydrogen bond0, else (3.8)
Hydrophobic interactions (iv). Hydrophobic interactions between ligand atoms and
protein effective points are modeled using a spatial hydrophobicity distribution and softened
Gaussian restraints. First, we calculate an empirical hydrophobicity, PHP (l), at the position
of a ligand atom l resulting from the surrounding P protein side chains within a distance








(7k2lp − 9k4lp + 5k6lp − k8lp)
]




where rlp is the distance between the l
th ligand atom and the pth protein effective point,
rmax has a fixed value of 9 Å [145], and klp = rlp/rmax. Ĥp is the hydrophobicity parameter
for the pth protein effective point accross to a scale derived for amino acids in globular
proteins from crystallographic data [146].
Next, we calculate a natural logarithm of the common Gaussian restraint with the
average hydrophobicity µHPl and the corresponding standard deviation σ
HP
l :















Ligand type-dependent parameters µHPl and σ
HP
l are derived from the eFindSite/PDB
dataset by calculating the average empirical hydrophobicity, PHP (l), and the corresponding
standard deviation for different ligand atom types.
The hydrophotic interaction score, EHP is taken as the average P
rest
HP calculated over






P restHP (l) (3.11)
Generic and pocket-specific contact potentials (v, vi). The molecular docking force field
implemented in GeauxDock also includes generic and pocket-specific contact potentials.
The generic potential, PCP , between the i
th ligand atom and the pth protein effective point
is calculated as follows:




where nlp is the observed number of contacts between ligand atoms of a similar type as l
and protein effective points of a similar type as p across the eFindSite/PDB dataset, and
n0lp is a reference number of contacts assuming no specificity [explained in eq. 3.4]. S(rlp)
is smoothing function defined as:
S(rlp) =
1





where rlp is the distance between l and p, and D
cnt
lp is the contact threshold that depends
on the types of both l and p.
The generic contact score, Ecp, is calculated by summing PCP values over all pairs of









PCP (l, p) (3.14)
In addition to the generic potential PCP derived from the eFindSite/PDB dataset, we
calculate P PSCP , a pocket-specific (PS) contact potential [75]. The PS version uses the same
formalism as the generic potential, however, rather than derived from the eFindSite/PDB,
the numbers of contacts nlp and n
0
lp are calculated using a set of evolutionarily related
complex structures identified for a given target protein by eThresd [147] and eFindSite [83].
Similar to ECP , the pocket-specific contact score, E
PS








P PSCP (l, p) (3.15)
Family conserved anchor substructures and pseudopharmacophore potential (vii, viii).
Ligands extracted from evolutionarily related complex structures are also used to impose a
series of harmonic restraints of family conserved anchor substructures, which were shown to
be highly effective in ligand docking [148], and to construct a new pseudopharmacophore
model. The former performs the chemical matching of a target ligand against all tem-
plate ligands using kcombu [94] to identify the maximum common substructures (MCS).
Subsequently, atomic equivalences within MCS provided by kcombu are used to calculate
a weighted average for RMSD values obtained against a set of A template ligands, with
weights corresponding to the target-template chemical similarity measured by the Tanimoto
coefficient [149]. A position restraint, PMCS, imposed on the ath anchor substructure, which
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where the summation runs over E pairs of equivalent atoms in the target and template
ligands sharing the ath anchor substructure, and rea is the atomic distance for the eth pair.
Typically, multiple templates and the corresponding anchor substructures are detected
for a given protein-ligand target, therefore, the final score taking into account family con-
served anchor substructures, EMCS, is calculated as the natural logarithm of the weighted







where TCa is the Tanimoto coefficient corresponding to the chemical similarity between
the ath template and the target molecule, and A is the total number of templates used to
extract the anchor substructures.
The second energy term in this group uses a pseudopharmacophore potential. Specif-
ically, it applies a Kernel Density Estimation (KDE) method to the positions of heavy
atoms of template ligands bound to the identified homologs to estimate a probability den-
sity function. We use a standard normal density function to describe the likelihood of an
atom of the docking ligand to be at a certain position within the binding site; the following





2 + (yl − ye)2 + (zl − ze)2
2h2
) (3.18)
where h is the bandwidth with a value of 0.5, l is a target ligand atom, and e is a template
ligand atom (l and e are of the same type). KDE provides a convenient way of data
smoothing, where inference about the population are made based on a finite data sample
[150,151].
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Kh(l, e), if type(e)=type(l)0, else (3.19)
Where E is the total number of template ligands.
The pseudopharmacophore score for a given configuration of a ligand within the binding







Distance restraint (ix). Finally, to limit the search space to the vicinity of a biding
site, the following distance constraint is imposed:
EDST = rcen (3.21)
where rcen is the distance between the ligand geometric center and the binding pocket
center predicted by eFindSite [83].
3.2.4 Ensemble docking
The flexibility of ligands and proteins in molecular docking is implemented using an
ensemble-based approach. This commonly used technique first precalculates an ensem-
ble of low-energy conformations and then performs a rigid-body docking for each con-
former [152, 153]. For ligands, we used a procedure described previously [148] to generate
nonredundant ensembles comprising up to 50 low-energy conformations whose pairwise
RMSD is > 1Å. Protein ensembles were constructed using Modeller [154] based on the
experimental structure of each target (self-modeling). We used only the coordinates of Cα
atoms belonging to nonbinding residues to fully explore the flexibility of ligand binding
regions. For each target proteins, 10 models were generated by Modeller through three
45
rounds of optimization using a variable target function method and molecular dynamics
refinement with the objective function set to 106.
3.2.5 Monte Carlo sampling
We use the Metropolis Monte Carlo (MMC) method [75, 155] to sample the confor-
mational space of protein-ligand interactions. This space consists of multiple subspaces
representing unique combinations of protein and ligand conformations from the precalcu-
lated ensembles. In the current implementation, each subspace is sampled independently
using the MMC method and the collected trajectories are merged at the end of simulations.
In each single MMC step, the position and orientation of a ligand are randomly perturbed
by translational and rotational steps about the x, y and z-axis of up to 0.02Å and 5 deg,
respectively. We found that this protocal allows a ligand to freely explore the conformation
space without compromising the precision. Furthermore, the temperature factor is chosen
such that the average acceptance ratio is about 0.5. Note that in GeauxDock, both the per-
turbation scale and the temperature factor can be modified to achieve a better performance
for particular systems. As MMC simulations search for the global minimum energy state
of a system, a scoring function implemented in GeauxDock is optimized to assign low pseu-
doenergy values to near-native conformations. Consequently, native-like binding modes are
frequently visited during the conformational sampling providing a sufficient resolution of
biologically relevant states.
3.2.6 Force field optimization
The total pseudoenergy score for a given configuration of a ligand binding site of its









The energy weight factors, w1 −w9, are optimized on a large and nonredundant set of
protein-ligand conformations constructed for the Astex/CCDC dataset [156]. Specifically,
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for each complex, we first generated 105 configurations through a series MMC simulations
including only the Lennard-Johns potential (i) to prevent steric clashes and the distance
constraint (ix) to confine the sampling to the vicinity of a binding pocket. Next, we cal-
culated pairwise CMS values for all conformations to create a 105 × 105 CMS matrix. To
remove redundancy, this matrix was subjected to clustering using CLUTO [157] result-
ing in 5000 groups; a cluster centroid was selected to represent each group. The final
dataset comprises 102,000 nonredundant protein-ligand configurations constructed for 204
complexes.
Subsequently, we compiled two subsets for the force field optimization, a group of
36,022 native-like conformations whose CMS values calculated against the experimental
complex structures are ≥ 0.6, and a set of 847,849 decoys with the CMS of ≤ 0.4. The
native-like recognition capability of the scoring function was enhanced by finding the set
of weights w1 − w9 [see eq. 3.22] that maximize the energy gap between native-like and
decoy conformations measured by the Z-score:





where < Ed > and < En > are the mean energy values calculated for native-like and decoy
conformations, respectively, with the corresponding standard deviations σn and σd.
We used the evolutionary search algorithm [144] emulating the principles of natural
evolution to identify the optimal set of energy weight factors that maximize the Z-score.
To avoid any bias, the optimization was performed 10 times starting from different initial
random sets of weights; the final weight factors were taken as the consensus of the 10
optimization rounds.
3.2.7 Other scoring functions
Two state-of-the-art algorithms, DrugScoreX (DSX) [122] and Ligand-Protein Contacts
(LPC) [158], were selected for comparative benchmarks of GeauxDock. DSX is a knowledge-
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based scoring function that features a distance-dependent pair potential, a torsion angle
potential, and a novel solvent accessible surface-dependent potential [122]. LPC uses a
scoring function that evaluates the geometric and chemical complementarity between a
ligand and its receptor protein [159]. Both programs were used with their default set of
parameters.
3.3 Results and discussion
3.3.1 Ensembles for pseudoflexible docking
It is well known that both proteins and ligands often undergo structural changes on
complex formation [135,160–162]; for instance, an analysis of 27 flexible ligands shows the
RMSD variation from 0.19 to 2.96 Å [162] calculated between single-crystal and protein-
bound states. A larger structural diversity is expected as the size of ligand molecules
increases; for instance, the conformational range for two ubiquitous compounds, nicoti-
namide adenine dinucleotide and vlavin adenine dinucleotide was calculated as 3.58 Å ±
0.08 and 3.49 Å ± 0.13, respectively, when bound to proteins [161]. On that account, an
accurate representation of biomolecules in simulations requires sampling multiple conforma-
tional states [163]. We use an ensemble docking technique to handle this issue in a discrete
manner. Specifically, conformers are selected from a precomputed pool of configurations
covering a large conformational space that includes biologically relevant molecules. In that
regard, we investigate the coverage of Astex/CCDC ligands by calculating RMSD values
using conformational ensembles and the corresponding experimental structures. The results
in terms of maximum, minimum, and medium RMSD values are presented in 3.1. Figure
3.1A shows that the median RMSD for 81% of the flexible ligands is within the reference
range of 0.19 to 2.96 Å [162] suggesting that the ligand flexibility is well represented across
the generate docking ensembles. Furthermore, the average plasticity of ligand-binding re-
gions in proteins expressed as the mean RMSD was estimated as 2.6 Å with a standard
deviation of 1.0 Å [164]. Protein ensembles constructed in this study fall within this range
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with the median binding site RMSD calculated over 204 ensembles of 2.61 Å, as shown
in Figure 3.1B. Collectively, these results demonstrate that conformational ensembles for
pseudoflexible docking provide a sufficient coverage of biologically relevant structures of
both ligands and their protein targets.
Figure 3.1: Structural characteristics of protein and ligand ensembles for pseudoflexible
docking. All-atom RMSD values are calculated using the native conformation for (A)
ligands and (B) protein binding sites. Dashed lines point out the estimated ranges of the
molecular plasticity. Blue, green, and red lines correspond to the maximum, minimum, and
median RMSD within each ensemble; molecules are sorted on the x-axis by their median
values.
3.3.2 Force field parameterization
Force fields for molecular modeling typically require a careful parameterization to repro-
duce experimental data. We derived the parameters for GeauxDock from the eFindSite/PDB
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dataset, a representative and nonredundant collection of protein-ligand complex structures.
Selected force field potentials parameterized against eFindSite/PDB are presented in Fig-
ure 3.2. Figure 3.2A shows the soft Lennard-Jones potential used to model va der Waals
interactions between effective points on Phe and Arg side chains, and selected ligand atoms.
The corresponding parameters ε that defines the depth of the potential well are reported
in Table 3.1 and Table 3.2. For instance, aromatic interactions between Phe-2 and C.ar,
and a salt bridge between Arg-2 and O.co2 have deeper potential wells with ε = 1.95
and ε = 1.54, respectively, compared to those less favorable, for example, Phe-2 and N.3
(ε = 1.07), and Arg-2 and N.am (ε = 0.43). Furthermore, the softened potential, which is
weaker at short distance than the translational form, is more appropriate to model interac-
tions involving effective points representing clouds of atoms rather than the hard spheres
of individual particles.
Table 3.1: Force field parameters (first part) for van der Waals interactions and the generic
contact potential for selected ligand atom types and protein effective points.
Protein point Parameter
Ligand atom type
C.3 C.ar C.cat N.3 N.am N.ar O.2
Calpha
ε 0.59 0.65 0.99 0.53 0.44 0.86 1.08
Pcp 0.21 0.09 -0.47 0.37 0.59 -0.33 -0.69
PP
ε 0.66 0.79 0.87 0.64 0.56 0.61 0.83
Pcp 0.1 -0.09 -0.2 0.13 0.32 0.22 -0.23
Phe-1
ε 0.63 0.77 1.3 0.64 0.3 0.63 0.75
Pcp 0.12 -0.1 -0.96 0.1 1.22 -0.1 -0.13
Phe-2
ε 1.77 1.95 1.58 1.07 1.34 1.95 1.46
Pcp -1.55 -1.79 -1.33 -0.69 -1.1 -1.72 -1.21
Arg-1
ε 0.19 0.21 0.12 0.47 0.18 0.26 0.39
Pcp 1.6 1.4 2.06 0.53 1.61 1.17 0.85
Arg-2 ε 0.63 0.55 0.27 0.7 0.43 0.62 1
Pcp 0.09 0.29 1.07 -0.01 0.63 0.14 -0.58
We also use a soft version of the electrostatic potential, where its values do not extend
to infinity when the interaction distance r approaches zero. As shown in Figure 3.2B, the
electrostatic potential creates a repulsion at close distances between those groups whose
partial charges have the same sign, whereas positively and negatively charged particles
attract each other. The strength of the interactions depends on the partial charges on
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Table 3.2: Force field parameters (second part) for van der Waals interactions and the
generic contact potential for selected ligand atom types and protein effective points.
Protein point Parameter
Ligand atom type
O.3 O.co2 P.3 S.3 S.O2 Cl
Calpha
ε 0.86 0.95 0.05 0.62 0.82 1.03
Pcp -0.26 -0.47 3.01 0.15 -0.19 -0.63
PP
ε 0.58 1.02 0.05 0.84 0.8 1.05
Pcp 0.14 -0.55 -0.69 -0.25 -0.14 -0.57
Phe-1
ε 0.43 0.55 0.26 0.79 0.3 1.07
Pcp 0.56 0.37 4.01 -0.18 0.87 -0.67
Phe-2
ε 1.29 1.6 1.17 1.66 0.82 2.19
Pcp -1 -1.27 -0.86 -1.48 -0.26 -2.11
Arg-1
ε 0.31 0.52 0.43 0.25 0.05 0.25
Pcp 1.18 0.36 0.63 1.1 3 1.29
Arg-2
ε 0.82 1.54 0 1.08 0.85 0.56
Pcp -0.31 -1.31 6.52 -0.8 0.04 0.29
individual groups. Table 3.3 lists net charges assigned to protein effective points by col-
lapsing AMBER partial charges of the constituent atoms. A point charge on the PP has
a fixed value of −0.246, which balances positively charged Cα atoms of individual amino
acids. Side chains of small hydrophobic residues are slightly positively charged, for exam-
ple, qp = 0.047 for Ile-1, in contrast to small polar amino acids that carry small negative
charges on their side chains, for example, qp = −0.046 for Ser-1. A small negatively charged
Asp has the unit charge assigned to its side chain effective point, whereas larger charged
residues have almost unit charge values; for example, the parameter qp is -0.792, 0.901, and
0.927 for Glu-2, Arg-2, and Lys-2, respectively. Partial charges on ligand heavy atoms are
calculated for individual compounds using the Mulliken population analysis [142], which is
widely used parameterization method in molecular docking.
Hydrogen bonds are modeled for hydrogen donor-acceptor pairs using single Gaussian
restraints. Table 3.4 lists force field parameters for hydrogen bonds and Figure 3.2C shows
the parameterized potential for selected pairs. Mean values for the interaction distance,
µHBlp , derived from the eFindSite/PDB dataset, give the optimal type-dependent bond
lengths, whereas σHBlp parameters that describe the deviation from average interaction
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Gly 0.246 - -
Ala 0.215 0.031 -
Asn 0.217 0.029 -
Asp 0.246 -1 -
Cys 0.088 0.158 -
Ile 0.199 0.047 -
Leu 0.204 0.042 -
Pro 0.112 0.119 -
Ser 0.292 -0.046 -
Thr 0.268 -0.022 -
Val 0.201 0.045 -
Arg 0.237 0.107 0.901
Glu 0.246 -0.208 -0.792
Gln 0.21 0.01 0.026
His 0.219 0.172 -0.145
Lys 0.227 0.092 0.927
Met 0.137 0.127 -0.018
Phe 0.214 0.049 -0.017
Trp 0.248 0.066 -0.068
Tyr 0.245 0.02 -0.02
distances across the dataset, control the interaction strength. For instance, µHBlp for Thr-1
and N.3 (3.59 Å) is slightly smaller than that for Tyr-2 and N.am (3.88 Å). Moreover, the
corresponding σHBlp are 0.95 and 0.78, respectively, thus, the strength of hydrogen bonded
pair of Tyr-2 and N.am at the optimal distance is greater than a hydrogen bond between
Thr-1 and N.3.
In our model, protein residues create a polar/hydrophobic local environment favor-
ing certain types of ligand atoms. These hydrophobic interactions are parameterized using
statistical collected for eFindSite/PDB protein-ligand complexes and a standard hydropho-
bicity scale for amino acids. The derived force field parameters reported in Table 3.5 are
in good agreement with physicochemical properties of ligand atom types. For example,
aromatic barbon atoms (µHPl = 0.11) and halogens (µ
HP
l = 0.24) tend toward nonpolar
residues, whereas amine nitrogen (µHPl = −0.27) and carboxylate oxygen (µHPl = −0.34)
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Table 3.4: Force field parameters for hydrogen bonds, µHBlp ±σHBlp , for selected ligand types




His-2 Ser-2 Thr-1 Tyr-2 PP
N.2 3.38 0.71 3.83 0.83 3.91 0.99 3.64 0.77 3.91 0.88
N.3 3.67 0.71 3.80 0.88 3.59 0.95 3.79 0.89 3.89 0.92
N.am 3.80 0.75 3.82 0.83 3.79 0.82 3.88 0.78 3.62 0.82
O.2 3.58 0.78 3.64 0.87 3.62 0.86 3.75 0.92 3.69 0.84
O.3 3.64 0.83 3.68 0.86 3.72 0.85 3.74 0.85 3.85 0.84
O.co2 3.50 0.76 3.45 0.87 3.64 0.92 3.46 0.86 3.75 0.86





C.3 -0.03 ± 0.43
C.ar 0.11 ± 0.46
C.cat -0.26 ± 0.43
N.3 -0.27 ± 0.44
N.am -0.10 ± 0.38
N.ar 0.03 ± 0.47
O.2 -0.21 ± 0.50
O.3 -0.28 ± 0.46
O.co2 -0.34 ± 0.46
P.3 -0.50 ± 0.41
S.3 -0.14 ± 0.45
S.O2 -0.10 ± 0.40
Cl 0.24 ± 0.52
atoms prefer a polar microenvironment. Hydrophobicity restraints P restHP for selected ligand
atom types are shown in Figure 3.2D as a function of the environment created by sur-
rounding amino acids. The extremes of -1.0 and 1.0 describe a strongly polar and nonpolar
character, respectively. The position of the function minimum determines the optimal envi-
ronment for a particular atom type described by PHP , thus, Cl and C.ar are on the positive
side, and N.am and O.3 are on the negative side of the protein hydrophobicity range.
Statistical potentials are commonly used components of molecular docking force fields
[165–167]. In this study, the parameters for pairwise interactions between ligand heavy
atoms and protein effective points were derived from the eFindSite/PDB dataset. The
53
log-odds potential expresses the likelihood of individual contacts, where the interactions
averaged over the entire dataset are taken as a reference state. Figure 3.2E shows the
extreme values for the contact potential between aromatic carbon C.ar and all types of
protein effective points. Clearly, aromatic moieties on the side chain effective points of
Phe-2, Trp-2, and Tyr-2, as well as the hydrophobic parts of Cys-1, Ile-1, Met-2, Leu-1,
and Val-1 make contacts with C.ar more often than by a random change. In contrast, the
polar and charged groups of Glu-1, Lys-1, Arg-1, Glu-2, and Lys-2 are statistically unlikely
to interact with ligand aromatic carbon atoms. Moreover, backbone effective points Cα
and PP have no distinct preferences toward interacting with C.ar.
In the GeauxDock force field, we use a smoothing function that is less sensitive to small
changes in ligand coordinates at the contact distance thresholds than the commonly used
step function. This is shown in Figure 3.2F for selected interactions between ligand heavy
atoms and protein effective points. For instance, salt bridges between Arg-2 and O.co2, and
Asp-1 and N.3 contribute half of their negative interaction energy at Dcntlp = 5.76 Å and
Dcntlp = 5.36 Å, respectively. Similarly, the positive energy contribution from destabilizing
interactions between Ala-1 and O.3, and Glu-2 and C.ar reach half of their values at the
corresponding contact thresholds. In addition to the generic contact potential derived from
the eFindSite/PDB dataset, we calculate its pocket-specific variant using evolutionarily
related complexes identified by sequence profile-based protein threading. These potentials
are specific toward a particular family of proteins, however, they contain significantly less
parameters compared with the genetic potential because of much smaller sample sizes (the
number of template complexes). For example, out of 720 pairwise parameters derived from
the eFindSite/PDB dataset for PCP , the average number of P
PS
CP parameters calculated
across the Astex/CCDC target pockets is only 110± 67. Nonetheless, the latter have been
demonstrated to be more accurate than the generic potential in the scoring and ranking of
ligand binding modes [75].
Different from traditional pharmacophore-based models that use known bio-active to
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calculate sets of steric and physicochemical features necessary for molecular recognition
[168], the pseudopharmacophore potential in GeauxDock is derived from evolutionarily
ligand-bound templates. Specifically, it estimates a probability for each ligand heavy atom
type to be at a certain position within the binding site. For instance, Figure 3.2G shows a
one-dimensional probability density for C.ar, N.am, O.co2, and O.3 along the x-coordinate
with the pocket centered at x=y=z=0 Å (the full potential is the product of probabilities
at x, y, and z coordinates). In this example, amine nitrogen and hydroxyl oxygen atoms
are most likely to be found at x=-1.4Å and x=-2.5Å, respectively. Carboxyl oxygen atoms
have a bimodal distribution typical for symmetric moieties with two equivalent peaks at
x = 0.4Å and x = 2.5Å, whereas aromatic aromatic carbon atoms have a relatively borad
probability of occurrence at −0.6 < x < 2.5Å. Favoring ligand heavy atoms at their high
probability positions predicts binding modes consistent with hte conserved evolutionary
profiles observed across set of homologous proteins.
3.3.3 Force field optimization
Force field weights were optimized on a large dataset of protein-ligand configurations
generated for Astex/CCDC complexes using the evolutionary search algorithm. The ob-
jective was to maximize the Z-score corresponding to the energy gap between native-like
and decoy conformations. Figure 3.3A shows the trajectory of Z-score in one complete
optimization process. The simulation converges within 400 generations, indicating an ef-
ficient update of weight factors. We performed the total of 10 simulations seeded with
random initial weight factors; each calculation resulted in the same set of weight factors
(w1 = 18.97, w2 = 0.78, w3 = 2.05, w4 = 0.53, w5 = 0.01, w6 = 0.53, w7 = 0.88, w8 = 110.82,
and w9 = 46.4), suggesting that the optimized values are stable and robust. Figures 3.3B
and 3.3C show the distribution of energy values with different sets of weights. In Figure
3.3B, random weight factors do not provide a clear separation between native-like (green
dots) and decoy (red dots) conformations whose median energy score is -1.67 and -1.03,
respectively. In contrast, Figure 3.3C shows that the optimized weight factors yield better
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energy-based partitioning of native-like and decoy conformations; here, native-like (decoy)
binding modes have a median energy of -0.16(0.58). This analysis suggests that the to-
tal pseudoenergy calculated using the optimized set of weights has a great potential to
effectively drive molecular docking toward correct ligand binding modes.
3.3.4 Recognition of native-like conformations
A strong capacity to identify native-like binding modes among a vast number of gener-
ated configurations plays a pivotal role in successful ligand docking simulations. Therefore,
in Figure 3.4, we conduct a comparative Receiver Operating Characteristics (ROC) analysis
of GeauxDock and two other scoring functions, DSX [122] and LPC [158]. Here, we use a
precompiled dataset of protein-ligand configurations comprising 36,022 native-like binding
poses and 847,849 decoys generated for Astex/CCDC complexes to uniformly cover the
conformational space. In general, all docking algorithms are capable of identifying cor-
rect conformations across the training MMC trajectories generated for the Astex/CCDC
dataset better than a purely random guess (dashed line). The area under the curve (AUC)
for the unoptimized GeauxDock force field (all weight factors set to 1.0) is 0.654 in contrast
to 0.851 for the optimized set of weights. For comparison, DSX pair, DSX pair sas and
LPC yield the AUC of 0.847, 0.858, and 0.765, respectively. Despite a slightly lower AUC,
GeauxDock gives 5% higher true positive rate than DSX pair sas at relatively small false
positive rates of 0.1-0.2. The results for DSX consistent with the original benchmarking
calculation [132] suggest that our dataset is of high quality and the CMS indeed provides
an effective evaluation metric.
Next, we performed full docking calculations using GeauxDock. The major difference
from the previous analysis is that these validation simulations start from a random ligand
conformation and use the complete, optimized force field to guide the conformational sam-
pling. MMC trajectories generated for the Astex/CCDC dataset are analyzed in Figure
3.5. First, for each benchmarking complex, we calculated the Z-score between native-like
and decoy conformations extracted from the docking trajectories. As shown in Figure 3.5A,
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90% of the cases have positive Z-score values indicating that ligand binding modes close to
native are systematically assigned a lower energy than those farther away from the exper-
imental conformation. The median Z-score across Astex/CCDC complexes is 1.0, which
is in accord with the training results reported in Figure 3.3. To further evaluate the qual-
ity of the GeauxDock force field, we calculated the Pearson correlation coefficient (PCC)
between the total pseudoenergy score and CMS. Figure 3.5B shows that in the majority
of the cases, the total pseudoenergy score and CMS are negatively correlated, that is, the
energy increases with the decreasing similarity to the experimental binding mode. Accord-
ing to the scale provided by Salkind [168], a very strong (−1.0≤PCC < −0.8), strong
(−0.8≤PCC < −0.6), moderate (−0.6≤PCC < −0.4), weak (−0.4≤PCC < −0.2), and
very weak or no correlation (−0.2≤PCC < 0.0) between energy and CMS was obtained for
3.43%, 15.20%, 28.43%, 25.49% and 14.22% of the Astex/CCDC complexes, respectively;
only 13.24% of the cases give the undesired positive correlation. Altogether, these results
demonstrate that the scoring function in GeauxDock is correctly optimized to drive MMC
simulations toward experimentally determined ligand binding modes.
3.3.5 Case studies
We select a couple of examples to demonstrate the accuracy of GeauxDock in finding
near-native ligand binding modes, cathepsin K complexed with a peptidomimetic inhibitor
(PDB-ID: 1bgo, chain A) [169], and actinidin complexed with an inhibitor E-64 (PDB-ID:
1aec, chain A) [170]. Both compounds were docked into the active sites of their target
protein using GeauxDock starting from a random initial conformation. The results are
shown in Figure 3.6 (panels A-C for cathepsin K and D-F for actinidin). First, we plot
the values of CMS calculated against inhibitors bound in the crystal complex structures,
and the total pseudoenergy and a low CMS for initial configurations indicate that ligands
are far away from their native states (Figure 3.6A and 3.6D). During MMC simulations,
a gradually decreasing energy E guides the conformational sampling to the vicinity of the
experimental binding modes of inhibitors as indicated by high CMS values at the end of
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simulations. Figure 3.6B and 3.6E demonstrate that in both cases, the optimized force field
yield a negative correlation between CMS and E, where each dot represents one MMC snap-
shot. Next, we select three representative conformations from those scatter plots for each
inhibitor, non-native (red), intermediate (orange), and near-native (green), whose CMS are
0.38, 0.49, and 0.90 for cathepsin K, and 0.38, 0.49 and 0.86 for actinidin, respectively. The
corresponding molecular representations are shown in Figure 3.6C and 3.6F using the same
color scheme. In both cases, low-energy binding modes (green) significantly overlap with
bound inhibitors in the experimental structures of cathepsin K and actinidin complexes
(ice blue sticks), whereas non-native and intermediate conformations are characterized by
notably higher pseudoenergy values.
3.3.6 Evolution- and physics-based components
A descriptor-based force field in GeauxDock combines evolution- and physics-based
scoring terms. The former are derived from evolutionary related complex structures at two
different sequence similarity thresholds, 80% to allow force field parameters to be calculated
from close homologs, and 40% to use only those templates that are weakly related to their
targets. Therefore, we can analyze how the level of homology affects the accuracy of
molecular docking. Using the Astex/CCDC dataset, the results are reported in Table 3.6
as the area under the ROC curve. As expected, the AUC significantly increases when
close homologs are included in forcefield optimization and the docking conformations are
evaluated by evolution-based components alone. In contrast, the performance of physics-
based scoring terms remains, to a large extent, unaffected by the maximum target-template
sequence identify, because these features are calculated from physical interactions that are
more universal [171]. Interestingly, the performance of GeauxDock using a complete force
field at a homology threshold of 80% is only slightly better than that at 40%, suggesting that
the descriptor-based scoring function is able to adapt to the supplied amount of evolutionary
information to maintain its accuracy.
To further investigate this intriguing observation, we calculated the relative contri-
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Table 3.6: Performance of GeauxDock on the Astex/CCDC dataset assessed by the area
under the curve (AUC). The force field is optimized at the homology thresholds of 40%




40% homology 80% homology
Complete 0.831 0.848
Evolution-based 0.699 0.745
Physics -based 0.801 0.814
bution of both classes of scoring terms to the total pseudoenergy at the two homology
thresholds. Figure 3.7 shows that the contribution from evolution-based components to
the total score is about 5% higher at 80% homology compared with 40%. Considering
only a slightly better performance of GeauxDock using close homologs, this analysis sug-
gests that the scarcity of evolutionary information can be effectively compensated by the
increased contribution from physics-based scoring terms. This unique feature of Geaux-
Dock is particularly important in its large-scale applications at the proteome level, such
as in inverse VS [172,173] and rational drug repositioning [174–176], where the availability
of only weakly homologous complex structures for the majority of drug targets will not
compromise the accuracy of molecular docking.
A well-balanced contribution of physics- and evolution-based energy terms to the total
pseudoenergy also suggests that these two classes of scoring features effectively complement
each other. Nevertheless, AUC values reported in Table 3.6 indicate that a linear combi-
nation of individual energy terms perhaps does not fully exploit their predictive power; for
instance, adding the evolution-based component improves the AUC of physics-based terms
by about 3%. This may be caused by the feature intercorrelation, which is known to limit
the performance improvements despite adding more descriptors [177]. A possible solution
is to combine individual energy terms using a nonlinear model, under the assumption that
noncovalent interactions often depend on one another in a nonlinear manner [178]. We will
explore the feasibility of a machine learning-based force field in ligand molecular docking
in the near future.
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3.4 Conclusions
In this study, we describe the development of GeauxDock, a molecular docking ap-
proach featuring a novel descriptor-based scoring function and a mixed-resolution descrip-
tion of protein-ligand complexes. The scoring function was parameterized on a large dataset
of crystal structures and further optimized using sets of computer-generated native-like
and decoy conformations. Encouragingly, benchmarking calculations demonstrate that
GeauxDock has a strong capacity to recognize native-like binding modes with the area
under ROC of 0.85. The descriptor-based scoring function implemented in GeauxDock
incorporates two distinct classes of energy terms, physics- and evolution-based. As the
latter are derived from evolutionary related complex structures, their strength depends
on the level of homology between the target and template systems. Interestingly, weak
evolutionary constraints are effectively compensated by the increased contribution from
physics-based terms, which, in turn, help maintain the accuracy of the GeauxDock scor-
ing function at the lower levels of protein sequence similarity. Therefore, this new ligand
docking approach is well suited for proteome-scale applications taking advantage of the
increasingly growing protein sequence and structural data. GeauxDock is available at
http://www.institute.loni.org/lasigma/package/dock/.
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Figure 3.2: Examples of selected force field potentials. (A) Type-dependent soft Lennard-
Jones potential, (B) soft electrostatic potential between protein effec- tive points and vari-
ous charges on ligand atoms q, (C) hydrogen bond restraints, (D) restraints for hydrophobic
interactions between different ligand atoms as a function of local hydrophobicity, (E) ex-
treme values for the log-odds potential between aromatic carbon C.ar and protein effective
points, (F) generic contact potential including a smoothing function, and (G) probability
density for different ligand atoms estimated by KDE along the x-axis.
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Figure 3.3: Force field optimization using the evolutionary algorithm. (A) The trajectory
of Z-score in the course of the optimization procedure. The distribution of pseudoenergy
values for native-like (green) and decoy (red) conformations for the (B) unoptimized and
(C) optimized force field. Boxes in B and C end at the quartiles Q1 and Q3, a horizontal
blue line in a box is the median, and whiskers show the 1.5 interquartile range.
Figure 3.4: Recognition of native-like conformations across docking trajectories. A ROC
plot for GeauxDock with an optimized force field is compared with those obtained using
the unoptimized force field as well as other scoring functions, DSX and LPC. TPR true
positive rate, FPR false posi- tive rate.
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Figure 3.5: Quality assessment for the optimized force field implemented in GeauxDock.
Histograms of (A) Z-score and (B) the PCC calculated from the Monte Carlo trajectories
collected for the Astex/CCDC dataset.
Figure 3.6: Docking results for (AC) cathepsin K and (DF) actinidin from GeauxDock.
(A, D) Monte Carlo trajectories for the Contact Mode Score (CMS) and the pseudoenergy,
(B, E) scatter plots of the CMS versus pseudoenergy, (C, F) representative conformations
taken from docking trajectories. In B, C, E, and F selected non-native, intermediate, and
near-native conformations are colored in red, orange, and green, respectively, whereas the
experimental binding poses are shown in ice blue.
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Figure 3.7: Balance of various energy terms in the optimized force field. The contribution
from physics- and evolution-based components is calculated at the thresholds of 80 and





1A number of computer programs have been developed to date for molecular dock-
ing simulation [179]. In general, using large compound databases increases the chances
of finding bioactives, however, large-scale virtual screening typically requires a long com-
puting time. In addition to the database size, computing time also increases with the
increasing accu- racy of the modeling of drug-protein interactions. Although sophisticated
models outperform simple approaches, these algorithms often have high demands for com-
putational resources. For example, docking accuracy can be improved by incorporating
the plasticity of biomolecules, e.g. using pre-generated ensembles of target protein struc-
tures [68]. Since ensemble- based docking requires conducting docking simulation for each
target conformation, the computational complexity increases linearly with the number of
conformers. Another approach to improve ligand docking incorporates the configurational
entropy. This property can be approximated by clustering ligand binding poses generated
by a docking program to calculate the conformational similarity between each pair of lig-
and modes, leading to O(n2) complexity, where n is the total number of binding poses.
Mining Minima provides a more accurate way to calculate entropy by integrating potential
energies as a function of coordinates, however, at a significantly increased computational
cos [69]. Finally, the simulation time can also affect docking accuracy for those docking
programs relying on stochastic methods to sample the free energy landscape, where longer
simulations are more likely to reach the global minimum [180].
Undeniably, achieving a good balance between docking accuracy and the computation
time represents a major challenge in structure-based virtual screening. To address this
problem, par- allel computing is often used to accelerate docking simulations. Parallel
1This section in the original published article is mainly accomplished by this dissertation author
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architectures fall into two broad categories: 1) small groups of tightly coupled processors
sharing a common memory space, and 2) large, scalable systems that do not share a
common memory. Both models often coexist in a high-performance computing (HPC)
environment; for instance, many HPC sys- tems use the distributed memory model to scale
up to thousands of multi-processor nodes, each employing the shared memory model. A
common programming practice for shared memory systems is to inform the compiler of parts
of the serial code to be executed in parallel by including extra hints, e.g. using OpenMP
pragmas [47]. In contrast, distributed memory systems require manually implemented
message-passing procedures, e.g. using Message Pass- ing Interface (MPI) protocols [46].
Parallel programming used to be a small niche until the tra- ditional single-core Central
Processing Unit (CPU) hit the ”instruction level parallelism wall and the ”clock speed
wall” [181] a decade ago. Although CPU vendors managed to bypass these limitations
by integrating more computing cores into a CPU, contemporary multi-core CPUs are not
the ultimate solution due to the power [182] and energy [183] problems. A new trend in
processor design to replace a handful of heavyweight cores with a massive amount of light-
weight computing units upthrust parallel programming to the mainstream.
In contrast to traditional CPUarchitectures designed to minimize the execution latency
of serial codes, highly simplified cores of modern accelerators are generally optimized for
high- throughput computations, therefore, their performance on latency-sensitive applica-
tions is often poor. Consequently, these computing units are usually attached to conven-
tional CPU- based systems as heterogeneous devices equipped with their own memory. Two
major accelera- tor architectures currently available, NVIDIA Graphics Processing Unit
(GPU) and Intel Xeon Phi, share some common features, but also have unique character-
istics. With respect to hard- ware, both accelerators as well as contemporary multi-core
CPUs share a two-level parallel design principle. The outer, coarse-grained level defines a
computation cluster whose individ- ual processing elements provide the inner, fine-grained
level of parallelism. With regard to software, each coarse-grained cluster handles its own
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programming context known as a thread on CPU and Xeon Phi, and a thread block defined
by the GPU Compute Unified Device Archi- tecture (CUDA) [48] paradigm. On CPU and
Xeon Phi, the inner level exposes data parallel- ism, viz. Single Instruction, Multiple Data
(SIMD) operations. NVIDIA GPU uses CUDA threads inheriting a similar principle of
vector processing. For instance, a bundle of 32 conse- cutive CUDA threads, denoted as
a warp, are scheduled together. Consequently, CUDA threads may go predication when
a small, conditionally protected piece of code is encountered, forcing the execution of all
instructions.
When different CUDA threads take different paths in multiple-path branches, more
cycles are consumed leading to a lower device utilization. Although SIMD instructions on
CPU and Xeon Phi have similar characteristics, the number of vector elements is about
one-quarter to one-half of that on GPU and the code generation heuristic can vary signifi-
cantly, therefore, an irregular code may perform dramatically differently on these platforms.
Another major differ- ence between CPU and Xeon Phi, and GPU is that the former imple-
ment hardware multi- threading at the outer level, whereas multi-threading on GPU is at
the inner level demanding more data parallelism. Compared to CPU, contemporary Xeon
Phi delivers roughly equal amount of raw compute power per core in terms of the number of
data operations per cycle. However, because of a larger number of computing cores on the
co-processor, it offers certain advantages over CPU in processing regular, highly parallel
workloads. On the other hand, CPU cores typically perform better for irregular workloads.
In addition to core characteristics, com- puting performance is also affected by memory
operations. Different from the automatic mem- ory management as cache on CPU and
Xeon Phi, GPU exposes to programmers its fast on- chip memory, known as the CUDA
shared memory.
A common programming practice for GPU is to exploit the parallelism using low-level
Application Programming Interfaces (APIs), such as CUDA and OpenCL [184]. GPU
program- ming typically comprises several stages, 1) identify parallel workloads, 2) copy
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data from the host to the device, 3) map workloads to computing cores, 4) determine a
suitable memory access for CUDA threads, 5) synchronize the execution between GPU
and CPU, and 6) copy data back to the host. Despite a significant effort directed to
help automate these steps, high- level GPU programming languages are still not versatile
enough to fully unleash the power of GPU for complex applications. In contrast, Xeon Phi
is designed to provide massive parallelism at considerably reduced programming efforts.
Intel compilers can generate Xeon Phi acceler- ated binaries in a similar way to compiling
traditional CPU codes [185], therefore, programming Xeon Phi in the native mode is fairly
comparable to coding for multiple-core CPUs. Similar to GPU, Xeon Phi also offers an
offload mode, where only selected portions of the code marked by compiler pragmas are
executed on the accelerator. OpenMP can be used in both native and offload modes
alleviating the need for low-level implementations.
In order to address computational challenges in structure-based virtual screening, sev-
eral docking programs offer HPC capabilities. For instance, AutoDock Vina [72] supports
multi- threading on CPU using the Boost::thread library yielding significant speedups on
multi-core processors compared to a serial version. Moreover, a CUDA implementation of
MolDock accelerates both the evolution search algorithm and its two-element scoring func-
tions on GPU [186], whereas PLANTS employs a systematic grid search with an accelerated
scoring function on GPUusing a high-level shading language [187]. A few projects take the
heterogeneous con- cept one step further by developing a hybrid docking framework that
can be executed on differ- ent computer architectures. For example, non-bonded interac-
tions in molecular dynamics kernels were parallelized for both GPU (using CUDA) and
CPU (using OpenMP), and further extended to fully utilize distributed platforms through
MPI protocols [188]. The docking engine BUDE [189] employs the OpenCL language to
maintain a parallel implementation of the genetic search algorithm for CPU, Xeon Phi and
GPU. Nonetheless, to the best of our knowledge, an efficient multiple-backend implementa-
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tion of the docking kernel based on Metropolis Monte Carlo (MMC) has not been reported
yet.
Recently, we developed GeauxDock, a new molecular docking package to model drug-
pro- tein complexes using a mixed-resolution molecular representation and the MMC search
engine [77]. GeauxDock uses non-hydrogen atoms for ligands, whereas proteins are de-
scribed at the coarse-grained, sub-residual level. Such a mixed-resolution description not
only helps tolerate structural deformations in the target binding sites caused by using pro-
tein models as docking targets, but also speeds up calculations by decreasing the number
of interaction points on mac- romolecules. The descriptor-based force field implemented
in GeauxDock includes nine energy terms carefully optimized to drive docking simula-
tions toward native-like conformations using a multi-replicaMMCsampling. Furthermore,
GeauxDock employs an ensemble-based approach to effectively model the flexibility of lig-
ands and proteins. Although GeauxDock sim- ulations typically converge in less than
1,000MMCcycles on standard datasets, its large-scale virtual screening applications remain
computationally challenging due to a large number of candidate molecules to be evaluated.
On that account, the present study describes our efforts porting GeauxDock to multi-core
CPUs and massively parallel accelerators, Xeon Phi and GPU. Computational models and
performance patterns are analyzed in detail for different architectures. We also discuss var-
ious code characteristics as well as general and platform-specific optimization techniques
used to turn GeauxDock into an ultra-fast docking tool for large-scale drug virtual screen-
ing.
4.2 Materials and methods
4.2.1 Virtual Screening Workflow
2GeauxDock is designed for virtual screening applications, where a given protein target
is screened against a large library of small organic compounds. A docking simulation of a
2The dissertation author contributed heavily to all the subsections in the Materials and Methods in the
original published work, but did not write the text
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single ligand is an independent computational task. Figure 4.1 shows four stages of virtual
screening using GeauxDock. The procedure starts with reading the input data and creating
a pool of tasks (Figure 4.1A). Protein and ligand files provide the initial coordinates of the
target protein and library compounds. The parameter file specifies various parameters,
such as coefficients to calculate energy terms, weight factors to linearly combine individual
energy components, as well as the length of rotation and translation vectors to perturb
ligand conformations duringMMCsimu- lations. Other files contain data to calculate a
pseudo-pharmacophore using the Kernel Density Estimation (KDE), restraints on family-
conserved anchor substructures using the Maximum Common Substructure (MCS), and
a pocket-specific potential (PSP). The KDE component of the scoring function describes
the likelihood of target ligand atoms to be at certain positions with respect to template-
bound ligand atoms, whereas the MCS term imposes root-mean- square deviation (RMSD)
restraints according to a chemical matching between the target ligand and template-bound
ligands collected from the PDB [77,83]. Further, PSP is a contact-based statistical potential
derived from weakly homologous holo-templates identified by threading rather than all
protein-ligand complexes present in the PDB [77, 190]. Once the required input data are
read and pre-processed, a computing device is initialized and the data is copied to the
accelerator (Figure 4.1B). Subsequently, docking calculations are performed for individual
tasks (Figure 4.1C) and finally, the output files are generated on the host (Figure 4.1D).
Preliminary testing of this workflow reveals that the redundant loading and parsing of the
same target protein when docking different ligands consumes up to 90% of the total I/O
time (Table 4.1 and 4.2). As a consequence of these excessive I/O operations, the execution
ofMMCkernels on GPUmakes for only 52% of the total simulation time. Furthermore, the
repetitive GPU memory allocation and de-allocation performed for each task takes almost
as much time as running the MMC kernel. Although the code for Xeon Phi is expected
to have similar issues, the compiler pragmas are placed inside theMMCkernel code, thus
the entire offload proce- dure combines data transfer and core calculations. The memory
70
management for the code off- load is not required in the CPU implementation. To address
the problem of the excessive I/O operations particularly for GPU-based platforms, the four-
step workflow for GeauxDock is arranged into two parts. The front-end consists of data
loading, pre-processing and creating a pool of tasks (Figure 4.1A), whereas the back-end
fetches tasks, initializes a computing device, exe- cutes the docking kernel, and periodically
saves the output data (Figure 4.1B-4.1D). With this design, the memory allocation and de-
allocation on GPU occur only once at the beginning and the end of the back-end process,
respectively.
Table 4.1: Time in ms required to complete various stages of a docking simulation by





Xeon Phi 214 21
GPU 216 21
4.2.2 Code Implementation
Docking simulations with GeauxDock can be conducted on three platforms, multi-core
CPU, GPU and Xeon Phi. Therefore, the source code is modularized for an easy mainte-
nance across different architectures (Figure 4.2). All three platforms share a common code
for front-end computations, whereas back-end codes have two versions, one for CPU and
Xeon Phi, and one for GPU. The C++ kernel employing OpenMP and Intel SIMD pragmas
is shared between CPU and Xeon Phi. Using the “-Doffload” flag enables additional prag-
mas protected by the “#ifdef offlow” macro, which which instruct the compiler to generate
Table 4.2: Time in ms required to complete various stages of a docking simulation by
GeauxDock for the 1a07 complex (second part).
Computing platform











CPU - - 4,848 - -
Xeon Phi 3,135 (initialization + simulation + output)
GPU 2,063 0.72 2,740 8 182
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Figure 4.1: Workflow of virtual screening using GeauxDock. (A) The front-end reads input
data and creates a pool of docking tasks. The back-end carries out three consecutive oper-
ations: (B) device initialization and data transfer, (C) docking calculations for individual
tasks, and (D) saving output data.
object files for Xeon Phi instead of CPU. In contrast, the GPU version comprises a C++
launcher and a docking kernel implemented in CUDA. This design allows for maintaining
a single front-end code and two versions of the back-end code. Compiling the source codes
(Figure 4.2A) generates architecture-specific object files (Figure 4.2B), which are linked to
create different versions of the binary (Figure 4.2C).
4.2.3 Parallelization Levels
GeauxDock features an enormous task-level parallelism, where different library com-
pounds docked against the target protein correspond to individual tasks. In addition, the
docking kernel exploits coarse- and fine-grained parallelism. Docking calculations for a sin-
gle task involve multiple protein and ligand conformations, where each unique combination
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Figure 4.2: Implementation of GeauxDock. (A) The code repository is divided into three
modules, a common front-end module for the CPU host and two back-end modules, one for
GPU and one for CPU and Xeon Phi. (B) Compiling the source codes produces a series of
architecture-specific object files. (C) Linking object files creates three binary versions for
GPU, CPU and Xeon Phi.
of protein-ligand conformations is regarded as a replica of the system. Although replicas can
be subjected to MMC simulations at different temperatures, only one temperature is cur-
rently used. For a given docking task, the corresponding ensembles of independent replicas
are suitable for coarse-grained parallel computing. Moreover, a fine-grained parallelization
takes place at the level of pairwise interactions between data points within each replica.
These interactions are computed as three matrices, proteinColumnV ector × ligandRowV ector
(PRT), KDEColumnV ector × ligandRowV ector (KDE), and MCSMatrix × ligandColumnV ector
(MCS). Here, a fairly large number of computations are subjected to fine-grained paral-
lelization; the analysis of input data reveals up to 104 data points for a single replica, which
is sufficient to saturate computing resources available on modern CPUs and accelerators.
Back-end calculations start when a task is fetched from the task pool. Figure 4.3
and Table 4.3 explain mapping between the docking algorithm and computing resources.
First, replicas within each task are mapped to coarse-grained resources, GPU streaming
multiprocessors (SMs) as well as CPU and Xeon Phi cores (Figure 4.3A and Table 4.3Name,
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Figure 4.3: Two levels of parallelism in the docking kernel. (A) At the coarse-grained
level, individual replicas are assigned to different CUDA thread blocks on GPU streaming
multiprocessors (SMs) and different threads on CPU/Xeon Phi cores. (B) At the fine-
gained level, data points for each replica are organized as Structure of Arrays containing
Cartesian coordinates x, y, z, and parameters p associated with atoms, such as type, charge,
and etc. Parameters for neighboring atoms are placed closely in memory to ensure the best
execution efficiency. (C) Data points at the fine-gained level are accessed in parallel by
CUDA threads on GPU and SIMD lanes on CPU and Xeon Phi.
Coarse-grained parallelism). When multiple GPUs are available, replicas within a given
task are evenly assigned to the attached GPU cards. Second, interaction-level calculations
(Figure 4.3B) are mapped to fine-grained resources, where computing 2D matrices utilizes
SIMD lanes on CPU and Xeon Phi, and CUDA threads on GPU (Figure 4.3 Table 4.3e,
Fine-grained parallelism). S1 Code illustrates loop operations on PRT, KDE, and MCS
matrices involving a number of summation reductions. For instance, five energy terms
calculated using the PRT matrix (Esoftele , E
soft
vdW , EHB, ECP and E
PS
CP ) are directly reduced
from 2D array to a scalar value. Another type of reduction is hierarchical, where a 2D
array a[i][j] is first reduced to a 1D array b[i] along the j-dimension, and then to a scalar
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Table 4.3: Algorithm mapping to hardware and software models of coarse- and fine-grained
parallelism in GeauxDock.


































value along the i-dimension. This technique is applied to selected data across all three
matrices, e.g. EHP in the PRT matrix, EKDE in the KDE matrix, and EMCS in the MCS
matrix. In order to implement hierarchical reductions on GPU, we made adjacent GPU
threads efficiently exchange data by scheduling the i-dimension as the outer loop, and the j-
dimension as the inner loop. Specifically, the outer (inner) loop iterates over ligandRowV ector
(proteinColumnV ector) for the PRT matrix, ligandRowV ector (KDEColumnV ector) for the KDE
matrix, and rows of MCSMatrix (columns of MCSMatrix) for the MCS matrix.
2D CUDA thread blocks are responsible for calculations on GPU (Figure 4.3A, green
rounded boxes). The shape and size of CUDA thread blocks are flexible and can be tuned
for the optimal performance. Given that the CUDA warp size is fixed at 32, the x-dimension
of the CUDA thread block is best defined as a multiple of 32. Also, the maximum number
of 1,024 threads per CUDA thread block restricts the y-dimension, for example, the size
of the y-dimension cannot be greater than 32 when x-dimension is 32, because 32 × 32
= 1024. However, the shapes of 2D interaction matrices do not always perfectly match
those of CUDA thread blocks. For instance, the x-dimension is always greater than the
y-dimension in PRT and KDE matrices, whereas a typical MCS matrix has the y-dimension
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Figure 4.4: Example of parallel calculations for a data matrix. A small, 96-element matrix
ligandColumnV ector proteinRowV ector is outlined in red, whereas the 4 × 4 CUDA thread
block iterating over the matrix is outlined in blue. Here, at least 6 cycles are required
to process the data matrix utilizing a total of 70 parallel threads (gray cells), while the
remaining 26 threads are idle (white cells). An optimal shape of CUDA thread blocks can
be constructed dynamically to improve the computational performance by reducing the
number of cycles required to traverse the data matrix.
greater than the x-dimension. Therefore, boundary conditions require a careful design of
CUDA thread blocks to leave a certain number of idle threads for the thread management.
This procedure is illustrated in Figure 4.4, where processing a small, 70-element data
matrix (outlined in red) requires at least six cycles of a 4 × 4 CUDA thread block (each
cycle is outlined in blue). With this setup, 70 parallel threads are fully utilized (gray cells),
leaving 26 threads idle (white cells). Overall, the number of CUDA threads is fixed at the
compiling time, but the optimal shape of the thread block is defined at the runtime, when
the input data become available. Here, the objective is to find the best combination of
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x- and y-dimensions consuming the least amount of computing cycles to traverse the data
matrix, where a computing cycle is defined as follows:
cycle = (ceiling(data size x/cuda threads x))×(ceiling(data size y/cuda threads y))
(4.1)
In practice, only a handful of configurations are valid; we enumerate and evaluate these
configurations to find the optimal solution. As an example, using Tesla K20Xm GPU with
1,024 threads per thread block, a typical configuration for PRT, KDE, MCS matrices is
128 × 8, 128 × 8, and 32 × 32, respectively. Different from the GPU version, the back-
end for CPU implemented in C++ with OpenMP pragmas assigns processor threads to
carry out computations for individual replicas (Figure 4.3A, blue rounded boxes). In or-
der to avoid thread migration and ensure the best cache locality, the environment variable
“OMP PROC BIND” is set to “true”. In addition, inner loops in data computations iter-
ating over proteinColumnV ector (PRT matrix), KDEColumnV ector (KDE matrix), and columns
of MCSMatrix (MCS matrix) are marked with vector pragmas to assist Intel compiler in
generating an efficient, vectorized code. Note that the same CPU code can be used on Xeon
Phi since almost all performance tuning techniques for CPU apply to this accelerator as
well. The major difference is that the code for Xeon Phi is required to be offloaded to the ac-
celerator, which is conceptually similar to GPU programming. The offload is accomplished
using compiler pragmas, i.e. “#pragma offload target (mic) in (data in) out (data out)”.
However, the present pragma-based Xeon Phi programming model was designed to offload
a block of code to only one device. The current implementation of GeauxDock works
only with a single Xeon Phi card. Although replicas could be distributed manually across
multiple accelerators, one should keep in mind that at least 240 replicas are required to
effectively utilize Xeon Phi. Since docking tasks have no more than 550 replicas, split-
ting the workload among multiple Xeon Phi cards would inadvertently decrease the overall
performance. In addition, any code modification targeting the Xeon Phi platform would
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complicate the code maintenance. In fact, workload sharing at the task level represents a
more practical and scalable approach, which will be implemented in the future release of
GeauxDock.
4.2.4 Data Structure
A docking task contains complex data, including read-only protein and ligand con-
formations, MMC simulation parameters, MCS, KDE and PSP force field parameters, as
well as the dynamic configuration and output data from individual replicas. GeauxDock
employs the Structure of Arrays (SoA) to store the data ensuring the best data locality.
For example, the SoA for the ligand conformation shown as S2 Code A contains elements
x[L], y[L], z[L], t[L], and c[L], representing x, y, z coordinates, the type, and electric charge
for all ligand atoms, respectively. L defines the maximum number of ligand atoms and it
is set at the compiling time. Figure 4.3B shows that the data associated with neighboring
atoms are stored in consecutive memory addresses in order to maximize the efficiency of
memory operations required for the fine-grained parallelization. With this design, CUDA
threads on GPU and SIMD lanes on CPU and Xeon Phi access these data in a stride-1
pattern as illustrated in Figure 4.3C. Data structures for protein conformations, MMC
simulation parameters, and PSP, KDE and MCS force field parameters are created in a
similar fashion. These data constitute the first-level SoA providing read-only information,
and are used as building blocks to construct the multiple-replica simulation context.
To systematically assemble replicas from these raw data, we created a data structure
called “ReplicaInfo”, whose purpose is to assemble a replica from the raw data using indirect
references to various arrays. The concept of “ReplicaInfo” is presented in Fig 5, where
two example replicas, (L1, P1, T1) and (L1, P3, T2), are created using indexes to the same
ligand conformation (L1), but different protein conformations (P1 and P3) and simulation
temperatures (T1 and T2). ReplicaInfo was designed to yield a high computational efficiency
of data exchange between replicas during parallel tempering MMC simulations [191], which
requires swapping only a few indexes rather than the associated large data arrays. Further,
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the ReplicaInfo structure is used to store the temporary simulation status, including energy
values and ligand orientations with respect to the target protein pocket. Simulation logs
are saved in the “Simlog” data structure, whose entry can also be found in ReplicaInfo. We
note that the ReplicaInfo can be modified during MMC simulations, while the associated
data are read-only.
Figure 4.5: S2 Code A: Data structure for a ligand conformation (first-level Structure of
Arrays)
Figure 4.6: S2 Code B: Data structure for a ligand-protein complex (second-level Structure
of Arrays
In addition to the first-level SoA, we designed the second-level SoA called the “Com-
plex”. S2 Code B provides the outermost container for the computation data. The elements
of Complex are various data structures, including protein and ligand conformations, MMC
simulation parameters, MCS, KDE and PSP force field parameters, ReplicaInfo, and the
data size. Essentially, a single instance of Complex SoA and Simlog hold all data associated
with a computation task. Because the memory for Complex and Simlog is allocated only
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once, when either the CPU/Xeon Phi or GPU version of GeauxDock is initiated, it must be
large enough to hold data for any docking tasks from the task pool. Docking calculations
for the CCDC/Astex dataset require about 5 MB of memory for each Complex, whereas
the entire Simlog would allocate about 1.5 GB of memory. In practice, only about 100 MB
of Simlog data need to be transferred to the host and saved on disk.
4.2.5 Data Rearrangement
Irregular code patterns caused by dynamic data may significantly affect the perfor-
mance. The docking kernel code contains conditional branches and indirect memory ref-
erences, for example, calculating a branch path depends on the distance between a ligand
atom and a protein point, which is changing in the course of MMC simulations. Although
it is difficult to speed up the code containing these dependencies, we improved the code
regularity for certain cases. For instance, incrementally sorting KDE data elements by the
atomic type t helps improve the regularity of the conditional code if (lig->t[index] ==
kde->t[index]) in a loop iterating over hundreds of KDE data points. Another example is
the indirect memory reference, such as d = array[ligand->t[index]][protein->t[index]].
Here, sorting ligand and protein objects by t greatly improves the locality of accessing ar-
ray elements. Altogether, data rearrangement enhances the performance of GeauxDock by
9.6%, 12.2% and 8.2%, on CPU, Xeon Phi and GPU, respectively.
4.2.6 Strength Reduction
In order to further speed up calculations within the docking scoring function, the
strength reduction technique is applied to reduce its computation complexity. Original
mathematical formulas for various energy terms in the MMC kernel are divided into pre-
processing and computation groups. The pre-processing combined with data transforma-
tion is conducted within the front-end of GeauxDock. An example is shown as S3 Code,
where the indirect memory reference prtconf.r[index] is removed from the original kernel
(S3 Code A) and included in the pre-processing stage (S3 Code B), leading not only to
a better memory locality, but also to fewer instructions in the optimized kernel. Another
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technique used to accelerate computations within the docking kernel is the reduction of the
arithmetic intensity. For instance, S4 Code A shows a part of the original kernel computing
the soft van der Waals potential, which includes 6 loads, 9 multiplications, 3 division and 5
power functions. To speed up the MMC kernel, some calculations are either moved to the
pre-processing step or executed between certain blocks of the code and then reused when
calculating the potential. As the result, the optimized code shown as S4 Code B has only
2 loads, 6 multiplications, 3 divisions and no power functions.
Figure 4.7: S3 Code A: Example of a data structure and the corresponding computation
before strength reduction
4.2.7 Architecture Specific Optimization
The power of accelerators can be fully utilized only when time is primarily spent on
computations rather than data communication. GeauxDock is implemented based on this
principle by moving compute-intensive MMC simulations to Xeon Phi and GPU. S5 Code
shows the MMC conformational sampling in ligand docking. First, a new configuration of
a ligand is generated by randomly perturbing the present configuration. Next, the energy
of the new configuration is calculated and compared to the energy of the old configuration
using the Metropolis algorithm [75, 155]; the new configuration is accepted with a certain
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Figure 4.8: S3 Code B: Data structure and computation after strength reduction improving
memory locality
Figure 4.9: S4 Code A: Part of the docking kernel before the strength reduction
probability to be used in the next iteration, otherwise it is rejected. Even though some
components of the docking kernel, such as evaluating the Metropolis criterion, are less
suitable for the parallelization on GPU and Xeon Phi, this approach yields a better overall
performance than offloading parts of the docking kernel. For instance, offloading only
energy calculations could potentially generate an excessive communication between the
host and the accelerator. In that case, advanced optimization techniques such as the
asynchronous kernel execution and data copying between multiple tasks would have to be
applied for a better performance. However, because extra communication is avoided in the
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Figure 4.10: S4 Code B: Part of the docking kernel after the reduction of the arithmetic
intensity
MMC kernel, the code requires no further optimization of data transfer.
For GPU, the memory is carefully managed within the GeauxDock code with heavily
reused variables, such as interaction distances, placed in registers. Moreover, the shared
memory is used for those frequently reused data, such as ligand coordinates and energy
parameters, which may have an irregular access pattern. Large arrays with the stride-1
parallel access pattern are defined as SoA, sorted for improved regularity, and saved in the
global memory. Importantly, level 1 data cache on Tesla K20Xm GPU does not buffer the
global memory traffic by default. The docking kernel has a good reuse pattern for PRT and
KDE matrices, therefore, inserting ldg intrinsic enables the level 1 data cache mechanisms
to enhance memory operations. This technique improves the GPU performance by 4%
for PRT and KDE matrices. In contrast, the cache optimization cannot be applied to
computations for the MCS matrix, which have no global data reuse at all.
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Figure 4.11: S5 Code: Conformational sampling with the Metropolis Monte Carlo algo-
rithm
Since the docking kernel invokes reduction operations, partial results in each CUDA
thread need to be added to a scalar value. Here, a simple implementation stores temporary
data in the shared memory, where the amount of the required memory scales linearly with
the number of CUDA threads. In the early version of GeauxDock, the capacity of the
shared memory limited the maximum number of CUDA threads per thread block to 768.
Since using more CUDA threads per block generally delivers a better performance on Tesla
K20Xm GPU, the current docking kernel uses shfl and shfl xor intrinsic instructions
for reduction operations. This technique enables a direct data exchange between CUDA
threads without consuming the shared memory. Not only is the new reduction code 3×
faster, but it also allows to use 1,024 CUDA threads per block improving the overall perfor-
mance by 40%. Finally, many elementary functions, exp, log, sin, cos, etc., are frequently
used in the docking kernel. The CUDA math library offers accelerated versions of these
math functions [48], which are enabled by the “-use fast math” compiler flag. This tuning
yields a 30% performance boost, however, the fast math intrinsic for GPU is not guaran-
teed to be fully compatible with the IEEE floating point standard. Nonetheless, a careful




The performance of MMC kernels in GeauxDock is evaluated on several computing
platforms using diverse input data. We conducted benchmarking calculations using four
Linux computers listed in Table 4.4, including a mainstream PC desktop, a PC desktop with
the latest consumer grade GPU, a heterogeneous HPC cluster node with both GPU and
Xeon Phi accelerators, and an HPC cluster node with two GPU cards. We set the optimiza-
tion level to “-O3” with the following additional flags for the Intel compiler: “-fno-fnalias
-ansi-alias -fargument-noalias” (to safely remove pointer aliases), “-ipo” (to enable inter-
procedural optimization), “-vec-threshold0” (to enable vectorization whenever possible),
and “-fma” (to enable the fused-multiplication-add code generation). Architectural events
listed in Table 4.5 were recorded by hardware counters using the Performance Application
Programming Interface (PAPI) library version 5.4.0 [192]. In addition, we implemented
timers directly in the code in order to measure the execution time of an arbitrary segment
of the code. We noticed that time measurements have minor fluctuations of 5%, therefore,
all timings are reported as the average over 8 independent runs.
Table 4.4: Hardware and software specification of four computing platforms used to evaluate
the performance of GeauxDock
Platform Processor Accelerator Compiler
D1 (desktop)
1 × Intel Core i7-2600
4c, 8t, 3.4GHz, Turbo
- Intel 14.0.2
D2 (desktop)
1 × Intel Xeon E5-2620
6c, 12t, 2.0GHz, Turbo
1 × GeForce GTX 980 GCC 4.4.7
C1 (HPC cluster)
2 × Intel Xeon E5-2680 v2
10c, 10t, 2.8GHz, Turbo
1 × Tesla K20Xm1




2 × Intel Xeon E5-2670
8c, 8t, 2.6GHz, Turbo
2 × Tesla K20Xm Intel 14.0.2
CUDA 5.5
Table 4.5: PAPI preset events used to assess the code performance.
PAPI event Description
PAPI LI DCM Number of level 1 data cache misses
PAPI BR MSP Number of branch mispredictions
PAPI TOT INS Total number of instructions
PAPI TOT CYCLES Total number of CPU cycles
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4.2.9 Benchmarking Dataset
Benchmarking calculations are carried out for a single target protein, the pp60(c-
src) SH2 domain complexed with ace-malonyl Tyr-Glu-(N,N-dipentyl amine) (PDB-ID:
1a07) [193] and a set of 204 drug compounds selected from the CCDC/Astex dataset [156].
1a07 represents a typical docking target with 344 protein effective points and an ensem-
ble of 11 protein conformations. Depending on the number of rotatable bonds, up to 50
conformations are generated for ligands, thus the ensemble-based docking employs up to
550 replicas (11 × 50) of individual systems. In addition to this default protocol, we test
the code scalability using a varying number of replicas at multiple temperatures. Other
parameters affecting the computational complexity are the number of non-hydrogen ligand
atoms and the number of points to compute the evolution-based components of the Geaux-
Dock force field, KDE and MCS. Although both KDE and MCS scoring terms are used to
calculate various restraints derived from homology rather than physical interactions, these
points are iterable from the computing point of view. Therefore, KDE and MCS interact-
ing points are equivalent to ligand atoms and protein effective points in the physics-based
components of the GeauxDock force field.
4.3 Results and discussion
4.3.1 Dataset and Simulation Characteristics
3The distributions of the number of replicas, ligand atoms, as well as KDE and MCS
points are shown in Figure 4.12. GeauxDock employs multiple replicas to account for the
flexibility of protein-ligand complexes, where each replica contains a unique combination
of protein and ligand conformations. The highest peak in Figure 4.12A at around 550
replicas corresponds to highly flexible compounds with multiple rotatable bonds, whereas
the smaller peak at around 11 replicas represents those rigid complexes having only a single
3The dissertation author helped with preparing the data for benchmarking and case study, but did not
write the text in the original published work
86
conformer. Given that the hydrogen atoms are omitted when counting atoms, the range
between 6 and 62 heavy atoms presented in Figure 4.12B agrees well with the qualifying
range for drug molecules according to the extended version of Lipinskis rule-of-five [194].
Because KDE points and rows in MCSMatrix are calculated using template-bound ligands
detected by the eFindSite algorithm [83,195] their distributions (Figure 4.12C and 4.12D,
respectively) depend on the number and size of ligands extracted from holo-templates.
Figure 4.12: Distribution of various parameters affecting docking time. The number of
(A) replicas, (B) ligand non-hydrogen atoms, (C) KDE points, and (D) rows in the MCS
matrix are shown for the dataset of 204 CCDC/Astex compounds. KDE (Kernel Density
Estimation) and MCS (Maximum Common Substructure) points are used to calculate
evolution-based components of the docking force field.
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Another important simulation parameter is the number of MMC cycles. We found that
1,000 MMC cycles is sufficient for production runs to converge. Since these calculations
require 4.8 to 61 minutes on various platforms, the average wall time for the docking kernel
is 1.4 seconds on the fastest machine (platform D2, Table 4.4) and 18 seconds on the slowest
computer (platform D1, Table 4.4). Because the number of replicas (up to 550) is multiplied
by the number of temperatures (up to 240) in our benchmarks, and several versions of the
docking code needed to be tested, the time required to complete simulations could be
hundreds times longer than that for production runs. Therefore, shorter simulations with
100 MMC cycles are used for benchmarking purposes.
4.3.2 Performance with an Ample Coarse-Grained Parallelism
The execution time for docking kernels includes not only computations but also time
required for the data transfer to and from accelerator devices. Moreover, the kernel per-
formance can be affected by the ensemble size (the number of replicas), because those
docking systems containing rigid ligands provide insufficient coarse-grained parallelism to
fully utilize computing resources. On that account, we first need to determine the ideal
performance as well as a performance penalty caused by the meager coarse-grained paral-
lelism. To address this problem, we conducted a series of simulations providing a sufficient
number of replicas to deliver an ample coarse-grained parallelism. Specifically, we used 400
replicas for a dual CPU with 20 cores and 20 threads, 2,400 replicas for Xeon Phi with 60
cores and 240 threads, and 280 replicas for GPU with 14 streaming multiprocessors and 14
CUDA thread blocks.
The performance of docking kernels on CPU is assessed using the C1 computing system
(Table 4.4). We first evaluate the serial performance by enabling only 1 thread on a
single processor core. Using the total number of CPU cycles according to the PAPI event
PAPI TOT CYCLES (Table 4.5) and the computing time measured by either the PAPI
timer or our timer, the average dynamic CPU clock rate is 3.58 GHz ± 0.02. Figure
4.13 shows several characteristics assessing the overall computational performance of the
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docking code. Computing PRT and KDE matrices are the major components of the docking
kernel (Figure 4.16A and 4.16D). Since the maximum reuse distances [196] for these data
(300 and 9000, respectively) are small enough to fit L1 data cache, the cache efficiency
in GeauxDock is very high. Indeed, in most cases, the number number of L1 data cache
misses per 103 instructions is less than 7 (Figure 4.13A), which is lower compared to a
broad distribution of 5-30 misses reported for thoroughly tuned SPEC CPU2006 benchmark
kernels [197] tested on the same CPU microarchitecture. Applying an additional loop tiling
transformation [196] to further reduce the reuse distance does not improve the performance.
Similarly, the number of branch mis-predictions per 103 instructions for the SPEC CPU2006
kernels is between 1 and 10 [197], therefore, the docking code is superior with no more
than 2 branch mis-predictions (Figure 4.13B). Moreover, GeauxDock achieves an average
instruction throughput rate of about 2, which is notably higher than 1.43 instructions per
cycle reported for the most efficient SPEC CPU2006 kernel [197]. This comparison with
the SPEC CPU2006 benchmark suite demonstrates that the serial, CPU version of the
docking kernel in GeauxDock is indeed highly optimized.
Figure 4.13: Performance characteristics for a single-threaded docking kernel on CPU. The
number of (A) level 1 data cache misses per 103 instructions, (B) branch miss-predictions
per 103 instructions, and (C) instructions per cycle.
Next, using the optimized serial CPU code as a baseline, we measure the performance
of the parallel versions of GeauxDock on a dual multi-core CPU, Xeon Phi and GPU using
the C1 computing system (Table 4.4). Enabling 20 threads on a dual CPU triggers the
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dynamic frequency scaling and decreases the average CPU clock rate to 3.07 GHz ± 0.11.
Figure 4.14A shows that the average speedup of multi-threaded GeauxDock over its serial
version is 17.22×0.06, which actually corresponds to the maximum theoretical speedup
accounting for the lower clock rate ( 20 × 3.07 GHz / 3.58 GHz ). Compared to the
serial code, the parallel docking kernel runs from 22× to 56× faster on Xeon Phi 7120P
(Figure 4.14B) and 10× to 38× faster on Tesla K20Xm GPU (Figure 4.14C). One should
bear in mind that the simulation time depends on not only the data size, but also the
relative amount of PRT, KDE and MCS computations. Further, the irregular portions of
the docking code are handled differently by various devices because of their architectural
characteristics causing variations across the dataset. As we mentioned in the introduction
section when discussing hardware design, the simpler computing units of Xeon Phi and
GPU are more susceptible to dynamic branches than sophisticated CPU cores.
4.3.3 Performance of Docking Kernel on Real Data
Next, we test the parallel performance of each platform against realistic workloads.
Figure 4.14D and 4.14F show that multi-threaded CPU and GPU versions of the docking
kernel generally maintain their high performance on real data. In contrast, the performance
of Xeon Phi is significantly affected by the lack of an ample coarse-grained parallelism
(Figure 4.14E). Although the co-processor is twice as fast as a dual CPU in 71.1% of
the cases (a speedup of 17× and more), Xeon Phi performs about twice as slow as a
dual CPU for the remaining docking systems. This double peak pattern matches the
bimodal distribution of the number of replicas shown in Figure 4.12A, demonstrating that
the computational throughput of Xeon Phi is significantly affected by those workloads
providing insufficient coarse-grained parallelism.
To further investigate the effect of the number of replicas on the parallel performance,
we compiled a separate testing dataset comprising a single conformation of the target
protein 1a07 and a rigid ligand adamantanone (PDB-ID: 5cpp) [198]. This docking system
is replicated n times at different temperatures to strictly control the number of replicas in
90
Figure 4.14: Distribution of speedups of parallel GeauxDock over the serial CPU version.
Benchmarking calculations are conducted for the dataset of 204 CCDC/Astex compounds
using (A-C, red) modified input data providing an ample coarse-grained parallelism and
(D-F, green) unmodified input data. Three kernel implementations are tested for (A, D)
multi-core CPU, (B, E) Xeon Phi, and (C, F) GPU.
docking simulations. The docking time for multi-core CPU, Xeon Phi and GPU kernels
are presented in Figure 4.15. Figure 4.15A and 4.15C show sets of horizontally parallel
lines with even vertical distances, whose width corresponds to the number of CPU cores
and GPU streaming multiprocessors, respectively. Here, replicas are processed in parallel
by independent computing units with the execution time equal to the number of replicas
divided by the core count. The width of horizontal lines for Xeon Phi shown in Figure 4.15B
is 240 because of the hardware multi-threading (60 cores × 4 threads per core). Clearly,
it is beneficial to place 4 threads on a single core in order to fully utilize the hardware.
Moreover, the kernel time for the first few data points at the beginning of each horizontal
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line is somewhat shorter demonstrating that the co-processor performance is affected
by the global resource contention.
Figure 4.15: Performance scaling of docking kernels with different numbers of system
replicas. Benchmarking calculations are performed using (A) multi-core CPU, (B) Xeon
Phi, and (C) GPU. The width of horizontal lines is 20 replicas for a dual 10-core CPU, 240
for a 60-core Xeon Phi with 4-way multi-threading, and 14 for a 14-multiprocessor GPU.
4.3.4 A Reliable Model for the Docking Performance
To further understand the performance characteristics, we analyze various components
of the docking kernel including the time spent on computing PRT, KDE, and MCS inter-
action matrices. KDE and MCS data are used to calculate evolution-based components of
the docking force field, whereas the PRT matrix is used to calculate physics-based poten-
tials. The time spent on computing the remaining operations is measured using a modified
kernel, in which PRT, KDE, and MCS calculations are disabled. Figure 4.16 shows time
contributions from these four components. Computing PRT contributes to 64.4%, 60.4%,
and 32.1% of the total execution time on CPU, Xeon Phi, and GPU, respectively (Figure
4.16A-C). The percentage of the kernel time for KDE is 33.9% on CPU, 28.2% on Xeon
Phi, and 46.3% on GPU (Figure 4.16D-F), whereas for MCS, it is 2.7% on CPU, 5.1%
on Xeon Phi, and 10.4% on GPU (Figure 4.16G-I). The remaining operations make up
about 10% of the total kernel time on Xeon Phi and GPU. In contrast, these computations
require almost no time on CPU because the sophisticated processor cores handle sequen-
tial workloads (e.g. updating ligand coordinates, generating random numbers, calculating
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Metropolis acceptance criterion, etc.) as efficiently as highly parallel workloads. Further,
the CPU code has no data transfer between the host and the accelerator, which is required
only for Xeon Phi and GPU.
Next, we analyze the correlation between the computing time and the static data
size. In addition to the original docking code, we examine the performance impact of
dynamic branches by forcing the calculation of all operations; this modified implementation
is referred to as a “regulated” code. Figure 4.17 shows the correlation between the execution
time and the data size for the original program in blue and the regulated code in red. Figure
4.17A-F demonstrate that the time required to calculate the PRT (KDE) matrix strongly
correlates with its size; the coefficient of determination, R2, for the original code shown
in blue is 0.996 (0.938) for CPU, 0.996 (0.987) for Xeon Phi, and 0.952 (0.981) for GPU.
This correlation is somewhat weaker for the MCS matrix with the R2 of 0.957, 0.720 and
0.793 for CPU, Xeon Phi and GPU, respectively. Forcing the execution of the entire code
by eliminating dynamic branches has two major effects on the kernel performance. First,
it improves the correlation between the computing time and the data size, for instance, the
R2 for the KDE matrix shown in red in Figure 4.17D-F is 0.999 for CPU and Xeon Phi,
and 0.983 for GPU. Second, the regulated code is slower, however, the relative increase
of the execution time is clearly architecture-dependent. In general, CPU skips executing
most of the instructions downstream of branches because their conditional outcome can
be accurately predicted, which yields a better performance (Figure 4.17A and 4.17D). The
performance of GPU (Figure 4.17C and 4.17F) is unaffected by branches indicating that this
accelerator always performs the predicated execution. Interestingly, the branch behavior
of Xeon Phi falls between CPU and GPU. For the PRT matrix (Fig 4.17B), Xeon Phi
performs the predicated execution similar to GPU, whereas the branch prediction clearly
helps reduce the execution time on Xeon Phi for the KDE matrix when the KDE elements
are sorted (Figure 4.17E). Nonetheless, the performance improvement for Xeon Phi is not
as large as that for CPU because its computing cores are simpler and the wider SIMD
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vectors are generally less suitable for irregular data.
The original code improves the performance of computing PRT and KDE, however, it
negatively impacts the calculation of the MCS. This effect can be attributed to the irregular-
ity and shape of the MCS data structure containing a dense ligandColumnV ector, but a sparse
MCSMatrix. Note that since proteinColumnV ector (Figure 4.17A-C) and KDEColumnV ector
(Figure 4.17D-F) data structures are 1D arrays, there is a branch pattern between different
elements, which can be further improved by data sorting. This pattern is lost in the sparse
MCSMatrix × ligandColumnV ector causing a significant branch prediction penalty and longer
execution times for CPU and Xeon Phi (Figure 4.17G and 4.17H). On the GPU platform,
we analyzed two versions of the generated Streaming ASSembly (SASS) code. The original
SASS code always performs predicated execution, while the regulated SASS code uses non-
predicated instructions without testing branch conditions. For that reason, the regulated
docking code performs better for the irregular MCS data.
As mentioned above, the correlation between the computing time and the size of the
MCS matrix also tends to be weaker than that for PRT and KDE matrices. For instance,
the R2 for the original (regulated) code shown in blue (red) in Figure 4.17G-I is 0.957
(0.946) for CPU, 0.720 (0.744) for Xeon Phi, and 0.793 (0.749) for GPU. This effect can be
explained by the fact that the MCS data matrix is limited by the number of ligand atoms,
which is between 6 and 62 for the CCDC/Astex dataset (Figure 4.12B). Consequently, the
MCS matrix is not wide enough to efficiently utilize vector lanes on CPU (8 elements) and
on Xeon Phi (16 elements) as well as the x-dimension of 2D CUDA thread blocks on GPU
(32 elements); see Table 4.3. Consider a ratio of the data size and the number of cycles:
ratio = data size x/cycles (4.2)
with the number of cycles required to traverse the x-dimension of the MCS matrix given
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by:
cycles = ceiling(data size x/vector width x) (4.3)
For PRT and KDE matrices, whose data size is much larger than the vector width, the ratio
in Equation 4.2 is close to the vector width yielding a strong linear correlation between the
computing time and data size. In contrast, performance fluctuations caused by idle cycles
created by the underutilized vector lanes (Equation 4.3) slightly decrease the correlation
for the MCS matrix.
Encouragingly, the time required to compute various interaction matrices scales linearly
with the static data size. Therefore, we developed the following general linear regression
model to estimate the wall clock time for the docking kernel:
time = w1PL+ w2KL+ w3ML+ c (4.4)
where, PL, KL, and ML are the sizes of PRT, KDE, and MCS matrices, respectively.
The fitted weights and the intercept (w1/w2/w3/c) are 7.493e-5/6.213e-6/5.121e-7/-0.025
for CPU, 2.343e-5/2.230e-6/5.937e-6/0.042 for Xeon Phi, and 4.798e-6/4.691e-6/1.783e-
6/0.222 for GPU. Figure 4.18 shows that this model allows us to accurately predict the
docking time from input data with the R2 of 0.974 on CPU (Figure 4.18A), 0.994 on Xeon
Phi (Figure 4.18B), and 0.980 on GPU (Figure 4.18C). For those docking cases providing
insufficient coarse-grained parallelism, we can further combine this linear regression with
the performance model for the coarse-grained scaling (Figure 4.15). Specifically, the linear
model predicts the average computing time for individual replicas assuming a sufficient
coarse-grained parallelism. Since this value corresponds to the height of the first horizontal
bar in Figure 4.15, we can estimate the execution time of a real task using the number of
replicas and the repeating pattern of the regulated code.
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4.3.5 Comparative Benchmarks of Platforms
Finally, we perform comparative benchmarks of all computing platforms listed in Table
4.4 using the 1a07 target protein and the dataset of 204 CCDC/Astex ligands. In these
simulations, we use the original GeauxDock code and the real data with respect to the
number of protein and ligand conformations. Timing reports include the total execution
time of the docking kernel for 204 tasks and the simulation wall time averaged over 8
independent docking runs for each task. GeauxDock is specifically designed for virtual
screening applications, therefore, it reads the target protein input data only once for a
given set of docking ligands. Indeed, GeauxDock spends from 95.4% (GeForce GTX 980)
to 99.7% (Xeon E5-2680 v2) of the total time executing docking kernels, while loading
and pre-processing input data take only about 10 seconds on average (Table 4.6 and 4.7).
The reference time required to complete docking calculations for the entire dataset is 61.31
minutes using a multi-threaded CPU version running on Core i7-2600 multi-core CPU
(platform D1, Table 4.4). Figure 4.20 shows that high-performance servers and hardware
accelerators yield significant speedups over a mainstream PC desktop. GeForce GTX 980 is
the fastest computing device in our tests, which achieves a 12.6× speedup and dramatically
reduces the wall time to only 4.84 minutes. Xeon Phi gives a 6.8× speedup corresponding
to the wall time of 9.00 minutes, whereas the performance of a single Tesla K20Xm card
with 11.14 minutes of wall time is about 23% worse than Xeon Phi. It is noteworthy that
we obtained almost a perfect scaling on multiple GPU cards; using a pair of K20Xm GPUs
increases the performance by 98%, compared with a single K20Xm GPU. A dual Xeon
E5-2680 CPU needs 16.99 minutes to complete docking calculations, which is about 3.6
faster than the baseline i7-2600 CPU running at a higher clock rate.
One should keep in mind that not only the theoretical peak performance, but also
the cost and the energy consumption vary greatly for the testing platforms, particularly
between consumer and server grade hardware (Table 4.6 and 4.7). For instance, a single
Core i7 2600 is 12 less expensive and requires 59% less energy than a dual Xeon E5-
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Table 4.6: Benchmarking data for docking simulations conducted for the CCDC/Astex






1 x Core i7-2600 (platform D1) 61.31 (61.15) 224
2 x Xeon E5-2680 v2 (platform C1) 16.99 (16.86) 992
1 x Xeon Phi 71200P (platform C1) 9.00 (8.79) 2553
1 x Tesla K20Xm (platform C1) 11.14 (11.01) 3936
2 x Tesla K20Xm (platform C2) 5.61 (5.46) 7872
1 x GeForce GTX 980 (platform D2) 4.84 (4.62) 4980
2680 CPU, whereas GeForce GTX 980 is more than 5 lower priced and requires 27% less
energy than Tesla K20Xm. For that reason, in addition to evaluating a pure computational
performance, we analyze the performance with respect to the energy consumption and
hardware cost. GeForce GTX 980 systematically outperforms other computing platforms,
for example, it gives a benefit of 6.5× per dollar and 7.3× per watt compared to the
reference D1 platform (Figure 4.20). This remarkable performance results from mapping
massively parallel computations and data structure to the GPU architecture. According
to vendor specifications, GeForce GTX 980 has a higher core utilization and better energy
efficiency than the previous generation Tesla K20Xm. Its streaming multiprocessors have
two-thirds of the number of scalar processors of Tesla K20Xm, yet the number of registers
is the same. Moreover, the size of the shared memory on GeForce GTX 980 is twice as large
as that on Tesla K20Xm. Therefore, extra efforts were devoted to tune the CUDA docking
kernel in order to take advantage of the abundant resources on GeForce GTX 980. The
performance per dollar of K20Xm GPU is comparable to a server grade Xeon E5-2680 CPU
and Xeon Phi 7120P, but it is 2× lower than a consumer grade Core i7 processor. Due to
advances in the semiconductor technology constantly improving the energy efficiency, the
performance per watt of a server grade hardware (Xeon E5 CPU, Xeon Phi and K20Xm)
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Table 4.7: Benchmarking data for docking simulations conducted for the CCDC/Astex
dataset using various computing devices (second part).
Computing device Power consumption [watt] Price [US dollar]
1 x Core i7-2600 (platform D1) 95 283
2 x Xeon E5-2680 v2 (platform C1) 230 3440
1 x Xeon Phi 71200P (platform C1) 300 4129
1 x Tesla K20Xm (platform C1) 225 3000
2 x Tesla K20Xm (platform C2) 450 6000
1 x GeForce GTX 980 (platform D2) 165 550
is about twice as high as that for an inexpensive, yet two years older Core i7 processor.
4.3.6 Case Study
To demonstrate how GeauxDock samples the conformational space when searching
for native conformations, in Figure 4.21, we present docking trajectories for several rep-
resentative examples. In addition to the target complex 1a07 used in the profiling and
benchmarking of parallel GeauxDock, we performed docking simulations of glutathione to
glutathione S-transferase (PDB-ID: 1aqw) [199], and a non-peptidyl, active site-directed
inhibitor LY178550 to human α-thrombin (PDB-ID: 1d4p) [200]. Docking ligands were
initialized at random orientations within target binding pockets to mimic a real applica-
tion, where the native conformations are unknown. Solid lines in Figure 4.21A show the
trajectories of the pseudo-energy E1, E2 and E3 for 1a07, 1aqw and 1d4p, respectively. In
all cases, the MMC sampling reached low-energy states with the fastest convergence for
E3. On the other hand, pseudo-energy variations for E1 and E2 are smaller compared to
E3, suggesting that the underlying energy surfaces for 1aqw and 1d4p are smoother.
In general, the convergence of molecular docking simulations is complicated by the fact
that a large fraction of the search space may be sterically forbidden [180] and sophisti-
cated scoring functions are often too sensitive to conformational changes in the binding
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regions [201]. To further investigate docking trajectories, we calculated the RMSD for each
accepted MMC step during the docking process of 1a07. Encouragingly, the dashed black
line in Figure 4.21A shows that the RMSD decreases with the decreasing pseudo-energy
owing to the fact that both quantities are strongly correlated (Figure 4.21B). Altogether,
these results demonstrate that the scoring function in GeauxDock effectively drives docking
simulations toward native-like conformations.
4.3.7 Comparison with Other Docking Software
Finally, in order to compare the docking accuracy of GeauxDock to the state-of-the-art,
we performed benchmarking calculations of GeauxDock and AutoDock Vina [72] against
the PDBbind dataset [202]. Here, we selected a set of 158 proteins whose length is below 600
residues. We ran both programs with the default parameters using randomized starting
conformations of the docking ligands. The docking box for Vina was set to an optimal
size based on the radius of gyration of query compounds, which was demonstrated to
maximize docking accuracy [89]. First, we carried out a classical self-docking experiment,
where the ligand is re-docked to the experimental protein structure co-crystalized with that
compound. The geometric center of a ligand bound in the experimental complex structure
was used as the binding pocket center for both programs. Docking accuracy is assessed
by the RMSD calculated over ligand heavy atoms. Figure 4.22 (Self-docking) shows that
the median ligand RMSD across the PDBbind dataset is 2.03 Åfor Vina and 2.43 Åfor
GeauxDock. A p-value of 0.52 calculated by the Mann-Whitney U test demonstrates that
the performance difference between Vina and GeauxDock in self-docking is statistically
insignificant.
GeauxDock was designed to work with not only experimental structures, but also
computer-generated models. Therefore, in addition to the self-docking experiment, we
used both programs to dock ligands to the homology models of target proteins. Specif-
ically, we constructed protein models for the PDBbind dataset using templates detected
by HHsuite [203], whose sequence identity to the target is ¡70%. Moreover, in the model-
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docking experiment, we employed binding sites identified by eFindSite [83, 195], so that
ligand docking is performed solely with the predicted structural data. This dataset is
clearly more challenging than that used in self-docking because of structural imperfections
in the modeled target sites; the average heavy-atom RMSD calculated over binding site
residues is 2.51Å±1.62. In addition, binding site locations are predicted with an average
distance of 2.48Å±1.57 from the experimental pocket center. As expected, Figure 4.22
(Model-docking) shows that the median RMSD values for ligands docked by both pro-
grams tend to be higher than those obtained in the former experiment. Compared to
self-docking, the median ligand RMSD for Vina increased by 4.30Åto 6.33 Å. However, the
median RMSD for GeauxDock is 4.77 Å, thus, it has increased only by 2.34 Å, a value
that roughly corresponds to the structural distortions of target binding sites. Further,
the p-value between both docking programs reported by the Mann-Whitney U test is now
0.00025 clearly demonstrating that GeauxDock significantly outperforms Vina in ligand
docking against protein models.
4.4 Conclusions
4In this communication, we discuss the optimization of a molecular docking code,
GeauxDock. GeauxDock features a novel scoring function and Monte Carlo-based con-
formational space sampling and it is designed for large-scale virtual screening applica-
tions using heterogeneous computer architectures. Because of its modular code framework,
GeauxDock supports modern multi-core CPU, as well as Xeon Phi and GPU accelera-
tors. Considerable efforts were devoted to minimize the data communication leading to
at least 95% of the time spent on executing MMC kernels. Further, we applied vari-
ous tuning techniques to significantly accelerate the docking kernel based on the perfor-
mance characteristics obtained by a meticulous code profiling using diverse input data.
For instance, a systematic optimization of the serial CPU code brought about not only
4The dissertation author helped with making the conclusions, but did not write the text in the original
published work
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a 6.5× speedup on a single computing core, but also a perfect scaling with the number
of cores on modern shared-memory platforms equipped with multiple sockets of multi-
core CPUs. Docking benchmarks conducted on many-core accelerators show that using
Xeon Phi 7120P yields 1.9× performance improvement over a dual-socket Xeon E5 CPU,
whereas the fastest GPU, GeForce GTX 980, achieves a 3.5× speedup over a dual CPU.
It is important to note that in addition to hardware capabilities, a thorough code tuning
for accelerator devices plays an important role in increasing the computational perfor-
mance. For example, an early version of the GeauxDock code running on Tesla K20Xm
was about 30% slower than a dual-socket Xeon E5 CPU, but after employing GPU intrin-
sic instructions, we were able to make K20Xm 53% faster. In addition to the evaluation
of a purely computational performance, we examined the energy consumption and hard-
ware costs. In conclusion, heterogeneous computing platforms, especially those equipped
with the latest GPU cards, offer significant advantages over traditional CPU-based sys-
tems. Using parallel codes optimized for modern heterogeneous HPC architectures can
significantly accelerate structure-based virtual screening applications. GeauxDock is open-
sourced and publicly available from our website at www.brylinski.org/geauxdock and
http://www.institute.loni.org/lasigma/package/dock/.
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Figure 4.16: Time breakdowns for docking kernels running on different platforms. Ker-
nel implementations for (A, D, G) multi-core CPU, (B, E, H) Xeon Phi, and (C, F,
I) GPU are tested. Three major operations compute the following interaction matri-
ces: proteinColumnV ector × ligandRowV ector (PRT, green), KDEColumnV ector ligandRowV ector
(KDE, red), and MCSMatrix ligandColumnV ector (MCS, blue). Purple areas correspond to
the remaining operations. KDE (Kernel Density Estimation) and MCS (Maximum Com-
mon Substructure) points are used to calculate evolution-based components of the docking
force field, whereas the PRT matrix is used to calculate the majority of physics-based po-
tentials. Results collected for the dataset of 204 CCDC/Astex compounds are sorted on
the x-axis with respect to increasing time of computing (A, B, C) PRT, (D, E, F) KDE,
and (G, H, I) MCS matrices.
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Figure 4.17: Correlation between computing time and static data size. Blue points are
collected from original GeauxDock, whereas red points correspond to a modified docking
code, where dynamic branches are turned off forcing the execution of all instructions.
Three major operations compute (A-C) proteinColumnV ector ligandRowV ector (PRT), (D-
F) KDEColumnV ector × ligandRowV ector (KDE), and (G-I) MCSMatrix ligandColumnV ector
(MCS) matrices. Three kernel implementations are tested for (A, D, G) multi-core CPU,
(B, E, H) Xeon Phi, and (C, F, I) GPU.
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Figure 4.18: Correlation between the estimated and real docking time. Simulation time is
estimated from static data size using a general linear regression model for (A) multi-core
CPU, (B) Xeon Phi, and (C) GPU.
Figure 4.19: Data indexing for multi-replica Monte Carlo simulations. Individual replicas
are multi-dimensional objects comprising different combinations of ligand (L) and protein
(P) conformations, and temperatures (T), as well as the same set of PSP, KDE, MCS
potentials and force field (FF) parameters. All these data are read-only, labeled with tags,
and accessible through indexes as depicted by arrows.
104
Figure 4.20: Benchmarks of GeauxDock against the CCDC/Astex dataset. Three mea-
sures are included, a pure computational performance, the performance divided by the
energy consumption, and the performance divided by the hardware cost. Measurements
for different platforms are normalized by the performance of Core i7-2600 CPU.
Figure 4.21: Examples of docking calculations using GeauxDock. Three cases are pre-
sented, a peptide ligand and C-src tyrosine kinase (PDB-ID: 1a07, black), glutathione
and glutathione S-transferase (PDB-ID: 1aqw, green), as well as LY178550 and human
-thrombin (PDB-ID: 1d4p, red). (A) Solid lines show the pseudo-energy plotted as a func-
tion of the accepted Metropolis Monte Carlo (MMC) step; a trajectory of the RMSD is
plotted for 1a07 (dashed black line). (B) Scatter plot of the RMSD and pseudo-energy for
1a07.
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Figure 4.22: Docking accuracy of AutoDock Vina and GeauxDock on the PDBbind dataset.
The performance is assessed by ligand heavy-atom RMSD calculated against experimental
binding poses. A horizontal line inside each box is the median, boxes end at the first and
the last quartile, and the whiskers span the distribution range of 10-90%. Two boxes on
the left correspond to the self-docking experiment, whereas two boxes on the right are




Molecular docking is a promising technique that can make use of the vast amount of
experimental data in structural biology for the purpose of rational drug design. This thesis
summons up my original research work on several aspects in this field.
I developed the Contact Mode Score, a metric that quantifies the conformational sim-
ilarity of protein-ligand complexes based on intermolecular contacts. Compared with the
traditional root-mean-square deviation, its advantages include mitigating the dependence
on the ligand size and taking into account the protein environment. I further developed
the eXtended Contact Mode Score that capitalizes on the conservation of ligand binding
across structurally similar pocket occupied by chemically similar ligands. It can be applied
to evaluate predicted structures from molecular docking, where a retrospective assessment
cannot be performed because the experimental structures of the majority of complexes are
unavailable. The eXtended Contact Mode Score sets a typical example of using the readily
available template data in structural biology.
I developed GeauxDock docking engine, a molecular docking approach featuring a
novel descriptor-based scoring function and a mixed-resolution description of protein-ligand
complexes. Benchmarks demonstrate that GeauxDock is capable of recognizing native-like
binding modes with the area under ROC of 0.85. The scoring function of GeauxDock
incorporates two distinct types of energy terms, physics- and evolution-based. The latter
are derived from evolutionary related complex structures, and their strength depends on
the level of homology between the target and template systems. In that regard, this new
approach is able to take advantage of the increasingly accumulating protein structural data.
Through collaboration, the GeauxDock docking engine was implemented onto modern
parallel computing architectures. The program supports multi-core CPU, as well as Xeon
Phi and GPU accelerators. High parallel efficiency has been achieved that 95% of the
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computing time is spent on executing the Monte Carlo kernels. In addition to the evaluation
of a purely computational performance, we also examined the energy consumption and
hardware costs. In conclusion, heterogeneous computing platforms, especially the ones
equipped with the latest GPU cards, provide significant advantages over traditional CPU-
based systems in processing large scale molecular docking simulations.
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